id	sid	tid	token	lemma	pos
ecj-10037	1	1	hrev_master	hrev_master	NOUN
ecj-10037	1	2	abstract	abstract	ADJ
ecj-10037	1	3	bupropion	bupropion	NOUN
ecj-10037	1	4	intranasal	intranasal	NOUN
ecj-10037	1	5	misuse	misuse	NOUN
ecj-10037	1	6	potential	potential	NOUN
ecj-10037	1	7	should	should	AUX
ecj-10037	1	8	be	be	AUX
ecj-10037	1	9	considered	consider	VERB
ecj-10037	1	10	in	in	ADP
ecj-10037	1	11	the	the	DET
ecj-10037	1	12	suspect	suspect	NOUN
ecj-10037	1	13	of	of	ADP
ecj-10037	1	14	sympathomimetic	sympathomimetic	ADJ
ecj-10037	1	15	syndrome	syndrome	NOUN
ecj-10037	1	16	for	for	ADP
ecj-10037	1	17	illicit	illicit	ADJ
ecj-10037	1	18	drug	drug	NOUN
ecj-10037	1	19	or	or	CCONJ
ecj-10037	1	20	medication	medication	NOUN
ecj-10037	1	21	intoxication	intoxication	NOUN
ecj-10037	1	22	.	.	PUNCT
ecj-10037	2	1	a	a	DET
ecj-10037	2	2	31	31	NUM
ecj-10037	2	3	-	-	PUNCT
ecj-10037	2	4	year	year	NOUN
ecj-10037	2	5	-	-	PUNCT
ecj-10037	2	6	old	old	ADJ
ecj-10037	2	7	man	man	NOUN
ecj-10037	2	8	was	be	AUX
ecj-10037	2	9	admitted	admit	VERB
ecj-10037	2	10	for	for	ADP
ecj-10037	2	11	intranasal	intranasal	ADJ
ecj-10037	2	12	misuse	misuse	NOUN
ecj-10037	2	13	of	of	ADP
ecj-10037	2	14	30	30	NUM
ecj-10037	2	15	crushed	crush	VERB
ecj-10037	2	16	tablets	tablet	NOUN
ecj-10037	2	17	of	of	ADP
ecj-10037	2	18	bupropion	bupropion	NOUN
ecj-10037	2	19	with	with	ADP
ecj-10037	2	20	adrenergic	adrenergic	ADJ
ecj-10037	2	21	mild	mild	ADJ
ecj-10037	2	22	presentation	presentation	NOUN
ecj-10037	2	23	.	.	PUNCT
ecj-10037	3	1	lorazepam	lorazepam	PROPN
ecj-10037	3	2	infusion	infusion	PROPN
ecj-10037	3	3	was	be	AUX
ecj-10037	3	4	started	start	VERB
ecj-10037	3	5	with	with	ADP
ecj-10037	3	6	complete	complete	ADJ
ecj-10037	3	7	clinical	clinical	ADJ
ecj-10037	3	8	resolution	resolution	NOUN
ecj-10037	3	9	.	.	PUNCT
ecj-10037	4	1	further	further	ADJ
ecj-10037	4	2	forensic	forensic	ADJ
ecj-10037	4	3	investigations	investigation	NOUN
ecj-10037	4	4	detected	detect	VERB
ecj-10037	4	5	a	a	DET
ecj-10037	4	6	bupropion	bupropion	NOUN
ecj-10037	4	7	serum	serum	NOUN
ecj-10037	4	8	and	and	CCONJ
ecj-10037	4	9	urine	urine	NOUN
ecj-10037	4	10	concentration	concentration	NOUN
ecj-10037	4	11	levels	level	NOUN
ecj-10037	4	12	at	at	ADP
ecj-10037	4	13	18	18	NUM
ecj-10037	4	14	hours	hour	NOUN
ecj-10037	4	15	from	from	ADP
ecj-10037	4	16	intake	intake	NOUN
ecj-10037	4	17	of	of	ADP
ecj-10037	4	18	1905.26	1905.26	NUM
ecj-10037	4	19	ng	ng	PROPN
ecj-10037	4	20	/	/	SYM
ecj-10037	4	21	ml	ml	PROPN
ecj-10037	4	22	and	and	CCONJ
ecj-10037	4	23	2001.57	2001.57	NUM
ecj-10037	4	24	ng	ng	PROPN
ecj-10037	4	25	/	/	SYM
ecj-10037	4	26	ml	ml	PROPN
ecj-10037	4	27	,	,	PUNCT
ecj-10037	4	28	respectively	respectively	ADV
ecj-10037	4	29	.	.	PUNCT
ecj-10037	5	1	this	this	DET
ecj-10037	5	2	case	case	NOUN
ecj-10037	5	3	of	of	ADP
ecj-10037	5	4	intranasal	intranasal	ADJ
ecj-10037	5	5	bupropion	bupropion	NOUN
ecj-10037	5	6	misuse	misuse	NOUN
ecj-10037	5	7	shared	share	VERB
ecj-10037	5	8	only	only	ADV
ecj-10037	5	9	some	some	DET
ecj-10037	5	10	features	feature	NOUN
ecj-10037	5	11	with	with	ADP
ecj-10037	5	12	oral	oral	ADJ
ecj-10037	5	13	overdose	overdose	NOUN
ecj-10037	5	14	,	,	PUNCT
ecj-10037	5	15	despite	despite	SCONJ
ecj-10037	5	16	a	a	DET
ecj-10037	5	17	plasma	plasma	NOUN
ecj-10037	5	18	concentration	concentration	NOUN
ecj-10037	5	19	five	five	NUM
ecj-10037	5	20	times	time	NOUN
ecj-10037	5	21	higher	high	ADJ
ecj-10037	5	22	than	than	ADP
ecj-10037	5	23	the	the	DET
ecj-10037	5	24	lowest	low	ADJ
ecj-10037	5	25	toxic	toxic	ADJ
ecj-10037	5	26	level	level	NOUN
ecj-10037	5	27	.	.	PUNCT
ecj-10037	6	1	nasal	nasal	PROPN
ecj-10037	6	2	bupropion	bupropion	PROPN
ecj-10037	6	3	snorting	snort	VERB
ecj-10037	6	4	in	in	ADP
ecj-10037	6	5	chronic	chronic	ADJ
ecj-10037	6	6	users	user	NOUN
ecj-10037	6	7	could	could	AUX
ecj-10037	6	8	have	have	VERB
ecj-10037	6	9	lower	low	ADJ
ecj-10037	6	10	toxicity	toxicity	NOUN
ecj-10037	6	11	compared	compare	VERB
ecj-10037	6	12	to	to	ADP
ecj-10037	6	13	other	other	ADJ
ecj-10037	6	14	snorted	snorted	ADJ
ecj-10037	6	15	stimulants	stimulant	NOUN
ecj-10037	6	16	but	but	CCONJ
ecj-10037	6	17	symptomatic	symptomatic	ADJ
ecj-10037	6	18	treatment	treatment	NOUN
ecj-10037	6	19	remains	remain	VERB
ecj-10037	6	20	the	the	DET
ecj-10037	6	21	gold	gold	ADJ
ecj-10037	6	22	standard	standard	NOUN
ecj-10037	6	23	for	for	ADP
ecj-10037	6	24	preventing	prevent	VERB
ecj-10037	6	25	complications	complication	NOUN
ecj-10037	6	26	.	.	PUNCT
ecj-10037	7	1	bupropion	bupropion	NOUN
ecj-10037	7	2	misuse	misuse	NOUN
ecj-10037	7	3	might	might	AUX
ecj-10037	7	4	rapidly	rapidly	ADV
ecj-10037	7	5	become	become	VERB
ecj-10037	7	6	a	a	DET
ecj-10037	7	7	concerning	concern	VERB
ecj-10037	7	8	issue	issue	NOUN
ecj-10037	7	9	and	and	CCONJ
ecj-10037	7	10	monitoring	monitoring	NOUN
ecj-10037	7	11	by	by	ADP
ecj-10037	7	12	healthcare	healthcare	NOUN
ecj-10037	7	13	professionals	professional	NOUN
ecj-10037	7	14	is	be	AUX
ecj-10037	7	15	needed	need	VERB
ecj-10037	7	16	.	.	PUNCT
ecj-10037	8	1	introduction	introduction	NOUN
ecj-10037	8	2	despite	despite	SCONJ
ecj-10037	8	3	being	be	AUX
ecj-10037	8	4	an	an	DET
ecj-10037	8	5	under	under	ADV
ecj-10037	8	6	-	-	PUNCT
ecj-10037	8	7	recognized	recognize	VERB
ecj-10037	8	8	phenomenon	phenomenon	NOUN
ecj-10037	8	9	,	,	PUNCT
ecj-10037	8	10	prescription	prescription	NOUN
ecj-10037	8	11	and	and	CCONJ
ecj-10037	8	12	over	over	ADP
ecj-10037	8	13	the	the	DET
ecj-10037	8	14	counter	counter	NOUN
ecj-10037	8	15	(	(	PUNCT
ecj-10037	8	16	otc	otc	PROPN
ecj-10037	8	17	)	)	PUNCT
ecj-10037	8	18	medication	medication	NOUN
ecj-10037	8	19	misuse	misuse	NOUN
ecj-10037	8	20	(	(	PUNCT
ecj-10037	8	21	a	a	DET
ecj-10037	8	22	practice	practice	NOUN
ecj-10037	8	23	known	know	VERB
ecj-10037	8	24	with	with	ADP
ecj-10037	8	25	the	the	DET
ecj-10037	8	26	term	term	NOUN
ecj-10037	8	27	“	"	PUNCT
ecj-10037	8	28	pharming	pharme	VERB
ecj-10037	8	29	”	"	PUNCT
ecj-10037	8	30	)	)	PUNCT
ecj-10037	8	31	is	be	AUX
ecj-10037	8	32	rapidly	rapidly	ADV
ecj-10037	8	33	becoming	become	VERB
ecj-10037	8	34	an	an	DET
ecj-10037	8	35	issue	issue	NOUN
ecj-10037	8	36	of	of	ADP
ecj-10037	8	37	world	world	NOUN
ecj-10037	8	38	-	-	PUNCT
ecj-10037	8	39	wide	wide	ADJ
ecj-10037	8	40	concern.1	concern.1	PROPN
ecj-10037	8	41	bupropion	bupropion	NOUN
ecj-10037	8	42	is	be	AUX
ecj-10037	8	43	an	an	DET
ecj-10037	8	44	atypical	atypical	ADJ
ecj-10037	8	45	antidepressant	antidepressant	NOUN
ecj-10037	8	46	with	with	ADP
ecj-10037	8	47	medical	medical	ADJ
ecj-10037	8	48	indication	indication	NOUN
ecj-10037	8	49	for	for	ADP
ecj-10037	8	50	major	major	ADJ
ecj-10037	8	51	or	or	CCONJ
ecj-10037	8	52	seasonal	seasonal	ADJ
ecj-10037	8	53	depressive	depressive	ADJ
ecj-10037	8	54	disorder	disorder	NOUN
ecj-10037	8	55	and	and	CCONJ
ecj-10037	8	56	smoking	smoking	NOUN
ecj-10037	8	57	cessation,2	cessation,2	VERB
ecj-10037	8	58	in	in	ADP
ecj-10037	8	59	addition	addition	NOUN
ecj-10037	8	60	to	to	ADP
ecj-10037	8	61	off	off	ADP
ecj-10037	8	62	-	-	PUNCT
ecj-10037	8	63	label	label	NOUN
ecj-10037	8	64	uses	use	NOUN
ecj-10037	8	65	for	for	ADP
ecj-10037	8	66	attention	attention	NOUN
ecj-10037	8	67	deficit	deficit	NOUN
ecj-10037	8	68	hyperactivity	hyperactivity	NOUN
ecj-10037	8	69	disorder	disorder	NOUN
ecj-10037	8	70	(	(	PUNCT
ecj-10037	8	71	adhd	adhd	NOUN
ecj-10037	8	72	)	)	PUNCT
ecj-10037	8	73	,	,	PUNCT
ecj-10037	8	74	obesity	obesity	NOUN
ecj-10037	8	75	,	,	PUNCT
ecj-10037	8	76	binge	binge	NOUN
ecj-10037	8	77	-	-	PUNCT
ecj-10037	8	78	eating	eat	VERB
ecj-10037	8	79	disorder	disorder	NOUN
ecj-10037	8	80	and	and	CCONJ
ecj-10037	8	81	some	some	DET
ecj-10037	8	82	substance	substance	NOUN
ecj-10037	8	83	use	use	NOUN
ecj-10037	8	84	disorder	disorder	NOUN
ecj-10037	8	85	(	(	PUNCT
ecj-10037	8	86	sud	sud	NOUN
ecj-10037	8	87	)	)	PUNCT
ecj-10037	8	88	(	(	PUNCT
ecj-10037	8	89	e.g.	e.g.	ADV
ecj-10037	8	90	cocaine	cocaine	NOUN
ecj-10037	8	91	and	and	CCONJ
ecj-10037	8	92	methamphetamine).3	methamphetamine).3	NOUN
ecj-10037	8	93	bupropion	bupropion	NOUN
ecj-10037	8	94	acts	act	VERB
ecj-10037	8	95	by	by	ADP
ecj-10037	8	96	blocking	block	VERB
ecj-10037	8	97	dopamine	dopamine	NOUN
ecj-10037	8	98	,	,	PUNCT
ecj-10037	8	99	norepinephrine	norepinephrine	NOUN
ecj-10037	8	100	and	and	CCONJ
ecj-10037	8	101	to	to	ADP
ecj-10037	8	102	a	a	DET
ecj-10037	8	103	lesser	less	ADJ
ecj-10037	8	104	extent	extent	NOUN
ecj-10037	8	105	serotonin	serotonin	NOUN
ecj-10037	8	106	reuptake	reuptake	NOUN
ecj-10037	8	107	.	.	PUNCT
ecj-10037	9	1	it	it	PRON
ecj-10037	9	2	also	also	ADV
ecj-10037	9	3	acts	act	VERB
ecj-10037	9	4	as	as	ADP
ecj-10037	9	5	an	an	DET
ecj-10037	9	6	antagonist	antagonist	NOUN
ecj-10037	9	7	on	on	ADP
ecj-10037	9	8	many	many	ADJ
ecj-10037	9	9	nicotine	nicotine	NOUN
ecj-10037	9	10	receptors.4	receptors.4	VERB
ecj-10037	9	11	its	its	PRON
ecj-10037	9	12	chemical	chemical	NOUN
ecj-10037	9	13	structure	structure	NOUN
ecj-10037	9	14	is	be	AUX
ecj-10037	9	15	similar	similar	ADJ
ecj-10037	9	16	to	to	ADP
ecj-10037	9	17	cathinone	cathinone	NOUN
ecj-10037	9	18	,	,	PUNCT
ecj-10037	9	19	a	a	DET
ecj-10037	9	20	natural	natural	ADJ
ecj-10037	9	21	stimulant	stimulant	NOUN
ecj-10037	9	22	extracted	extract	VERB
ecj-10037	9	23	from	from	ADP
ecj-10037	9	24	catha	catha	PROPN
ecj-10037	9	25	edulis	eduli	NOUN
ecj-10037	9	26	,	,	PUNCT
ecj-10037	9	27	and	and	CCONJ
ecj-10037	9	28	therefore	therefore	ADV
ecj-10037	9	29	it	it	PRON
ecj-10037	9	30	is	be	AUX
ecj-10037	9	31	comprised	comprise	VERB
ecj-10037	9	32	within	within	ADP
ecj-10037	9	33	the	the	DET
ecj-10037	9	34	pharmacological	pharmacological	ADJ
ecj-10037	9	35	class	class	NOUN
ecj-10037	9	36	of	of	ADP
ecj-10037	9	37	substituted	substitute	VERB
ecj-10037	9	38	cathinones	cathinone	NOUN
ecj-10037	9	39	along	along	ADP
ecj-10037	9	40	with	with	ADP
ecj-10037	9	41	other	other	ADJ
ecj-10037	9	42	synthetic	synthetic	ADJ
ecj-10037	9	43	compounds	compound	NOUN
ecj-10037	9	44	(	(	PUNCT
ecj-10037	9	45	e.g.	e.g.	ADV
ecj-10037	9	46	amphetamines	amphetamine	NOUN
ecj-10037	9	47	and	and	CCONJ
ecj-10037	9	48	‘	'	PUNCT
ecj-10037	9	49	bath	bath	NOUN
ecj-10037	9	50	salts’).5	salts’).5	NOUN
ecj-10037	9	51	bupropion	bupropion	NOUN
ecj-10037	9	52	has	have	VERB
ecj-10037	9	53	a	a	DET
ecj-10037	9	54	narrow	narrow	ADJ
ecj-10037	9	55	therapeutic	therapeutic	ADJ
ecj-10037	9	56	window	window	NOUN
ecj-10037	9	57	,	,	PUNCT
ecj-10037	9	58	leading	lead	VERB
ecj-10037	9	59	to	to	ADP
ecj-10037	9	60	severe	severe	ADJ
ecj-10037	9	61	cases	case	NOUN
ecj-10037	9	62	of	of	ADP
ecj-10037	9	63	overdose	overdose	NOUN
ecj-10037	9	64	with	with	ADP
ecj-10037	9	65	possible	possible	ADJ
ecj-10037	9	66	fatal	fatal	ADJ
ecj-10037	9	67	complication	complication	NOUN
ecj-10037	9	68	such	such	ADJ
ecj-10037	9	69	as	as	ADP
ecj-10037	9	70	seizures6	seizures6	ADJ
ecj-10037	9	71	and	and	CCONJ
ecj-10037	9	72	heart	heart	NOUN
ecj-10037	9	73	failure.7	failure.7	NOUN
ecj-10037	9	74	despite	despite	SCONJ
ecj-10037	9	75	the	the	DET
ecj-10037	9	76	belief	belief	NOUN
ecj-10037	9	77	of	of	ADP
ecj-10037	9	78	bupropion	bupropion	NOUN
ecj-10037	9	79	having	have	VERB
ecj-10037	9	80	a	a	DET
ecj-10037	9	81	lesser	lesser	ADV
ecj-10037	9	82	addictive	addictive	ADJ
ecj-10037	9	83	potential	potential	NOUN
ecj-10037	9	84	compared	compare	VERB
ecj-10037	9	85	to	to	ADP
ecj-10037	9	86	cocaine	cocaine	NOUN
ecj-10037	9	87	or	or	CCONJ
ecj-10037	9	88	amphetamines,5	amphetamines,5	ADJ
ecj-10037	9	89	issues	issue	NOUN
ecj-10037	9	90	about	about	ADP
ecj-10037	9	91	its	its	PRON
ecj-10037	9	92	non	non	ADJ
ecj-10037	9	93	-	-	ADJ
ecj-10037	9	94	medical	medical	ADJ
ecj-10037	9	95	use	use	NOUN
ecj-10037	9	96	have	have	AUX
ecj-10037	9	97	been	be	AUX
ecj-10037	9	98	raised	raise	VERB
ecj-10037	9	99	for	for	ADP
ecj-10037	9	100	years1	years1	NOUN
ecj-10037	9	101	especially	especially	ADV
ecj-10037	9	102	among	among	ADP
ecj-10037	9	103	young	young	ADJ
ecj-10037	9	104	adults8	adults8	NOUN
ecj-10037	9	105	and	and	CCONJ
ecj-10037	9	106	inmates	inmate	NOUN
ecj-10037	9	107	in	in	ADP
ecj-10037	9	108	correctional	correctional	ADJ
ecj-10037	9	109	facilities.9	facilities.9	NOUN
ecj-10037	9	110	its	its	PRON
ecj-10037	9	111	recreational	recreational	ADJ
ecj-10037	9	112	snorting	snorting	NOUN
ecj-10037	9	113	misuse	misuse	NOUN
ecj-10037	9	114	has	have	AUX
ecj-10037	9	115	been	be	AUX
ecj-10037	9	116	reported	report	VERB
ecj-10037	9	117	since	since	SCONJ
ecj-10037	9	118	2002,10	2002,10	NUM
ecj-10037	9	119	whereas	whereas	SCONJ
ecj-10037	9	120	overdose	overdose	ADJ
ecj-10037	9	121	ingestion	ingestion	NOUN
ecj-10037	9	122	is	be	AUX
ecj-10037	9	123	more	more	ADV
ecj-10037	9	124	associated	associate	VERB
ecj-10037	9	125	with	with	ADP
ecj-10037	9	126	suicidal	suicidal	ADJ
ecj-10037	9	127	attempts.11	attempts.11	PROPN
ecj-10037	9	128	intravenous	intravenous	ADJ
ecj-10037	9	129	(	(	PUNCT
ecj-10037	9	130	iv	iv	X
ecj-10037	9	131	)	)	PUNCT
ecj-10037	9	132	bupropion	bupropion	NOUN
ecj-10037	9	133	abuse	abuse	NOUN
ecj-10037	9	134	has	have	AUX
ecj-10037	9	135	also	also	ADV
ecj-10037	9	136	been	be	AUX
ecj-10037	9	137	reported12	reported12	AUX
ecj-10037	9	138	sometimes	sometimes	ADV
ecj-10037	9	139	leading	lead	VERB
ecj-10037	9	140	to	to	ADP
ecj-10037	9	141	serious	serious	ADJ
ecj-10037	9	142	complications.13	complications.13	NOUN
ecj-10037	9	143	we	we	PRON
ecj-10037	9	144	hereby	hereby	ADV
ecj-10037	9	145	present	present	VERB
ecj-10037	9	146	a	a	DET
ecj-10037	9	147	case	case	NOUN
ecj-10037	9	148	of	of	ADP
ecj-10037	9	149	nasal	nasal	NOUN
ecj-10037	9	150	sniffing	sniffing	NOUN
ecj-10037	9	151	of	of	ADP
ecj-10037	9	152	a	a	DET
ecj-10037	9	153	huge	huge	ADJ
ecj-10037	9	154	amount	amount	NOUN
ecj-10037	9	155	of	of	ADP
ecj-10037	9	156	bupropion	bupropion	NOUN
ecj-10037	9	157	crushed	crush	VERB
ecj-10037	9	158	tablets	tablet	NOUN
ecj-10037	9	159	,	,	PUNCT
ecj-10037	9	160	requiring	require	VERB
ecj-10037	9	161	benzodiazepine	benzodiazepine	NOUN
ecj-10037	9	162	(	(	PUNCT
ecj-10037	9	163	bzd	bzd	NOUN
ecj-10037	9	164	)	)	PUNCT
ecj-10037	9	165	infusion	infusion	NOUN
ecj-10037	9	166	without	without	ADP
ecj-10037	9	167	the	the	DET
ecj-10037	9	168	development	development	NOUN
ecj-10037	9	169	of	of	ADP
ecj-10037	9	170	any	any	DET
ecj-10037	9	171	major	major	ADJ
ecj-10037	9	172	complication	complication	NOUN
ecj-10037	9	173	.	.	PUNCT
ecj-10037	10	1	case	case	NOUN
ecj-10037	10	2	report	report	NOUN
ecj-10037	10	3	in	in	ADP
ecj-10037	10	4	april	april	PROPN
ecj-10037	10	5	2021	2021	NUM
ecj-10037	10	6	,	,	PUNCT
ecj-10037	10	7	a	a	DET
ecj-10037	10	8	31	31	NUM
ecj-10037	10	9	-	-	PUNCT
ecj-10037	10	10	year	year	NOUN
ecj-10037	10	11	-	-	PUNCT
ecj-10037	10	12	old	old	ADJ
ecj-10037	10	13	man	man	NOUN
ecj-10037	10	14	was	be	AUX
ecj-10037	10	15	referred	refer	VERB
ecj-10037	10	16	to	to	ADP
ecj-10037	10	17	the	the	DET
ecj-10037	10	18	emergency	emergency	NOUN
ecj-10037	10	19	department	department	NOUN
ecj-10037	10	20	2	2	NUM
ecj-10037	10	21	hours	hour	NOUN
ecj-10037	10	22	after	after	ADP
ecj-10037	10	23	sniffing	sniff	VERB
ecj-10037	10	24	30	30	NUM
ecj-10037	10	25	crushed	crushed	ADJ
ecj-10037	10	26	bupropion	bupropion	NOUN
ecj-10037	10	27	tablets	tablet	NOUN
ecj-10037	10	28	“	"	PUNCT
ecj-10037	10	29	for	for	ADP
ecj-10037	10	30	playful	playful	ADJ
ecj-10037	10	31	purpose	purpose	NOUN
ecj-10037	10	32	”	"	PUNCT
ecj-10037	10	33	.	.	PUNCT
ecj-10037	11	1	his	his	PRON
ecj-10037	11	2	medical	medical	ADJ
ecj-10037	11	3	history	history	NOUN
ecj-10037	11	4	was	be	AUX
ecj-10037	11	5	positive	positive	ADJ
ecj-10037	11	6	for	for	ADP
ecj-10037	11	7	adhd	adhd	NOUN
ecj-10037	11	8	treated	treat	VERB
ecj-10037	11	9	with	with	ADP
ecj-10037	11	10	psy	psy	PROPN
ecj-10037	11	11	emergency	emergency	PROPN
ecj-10037	11	12	care	care	PROPN
ecj-10037	11	13	journal	journal	PROPN
ecj-10037	11	14	2021	2021	NUM
ecj-10037	11	15	;	;	PUNCT
ecj-10037	11	16	volume	volume	NOUN
ecj-10037	11	17	17:10037	17:10037	NUM
ecj-10037	11	18	correspondence	correspondence	NOUN
ecj-10037	11	19	:	:	PUNCT
ecj-10037	11	20	simone	simone	NOUN
ecj-10037	11	21	sartori	sartori	PROPN
ecj-10037	11	22	,	,	PUNCT
ecj-10037	11	23	medical	medical	ADJ
ecj-10037	11	24	toxicology	toxicology	NOUN
ecj-10037	11	25	unit	unit	NOUN
ecj-10037	11	26	and	and	CCONJ
ecj-10037	11	27	poison	poison	NOUN
ecj-10037	11	28	control	control	NOUN
ecj-10037	11	29	centre	centre	NOUN
ecj-10037	11	30	,	,	PUNCT
ecj-10037	11	31	viale	viale	PROPN
ecj-10037	11	32	san	san	PROPN
ecj-10037	11	33	luca	luca	PROPN
ecj-10037	11	34	vecchio	vecchio	PROPN
ecj-10037	11	35	,	,	PUNCT
ecj-10037	11	36	careggi	careggi	PROPN
ecj-10037	11	37	university	university	NOUN
ecj-10037	11	38	hospital	hospital	NOUN
ecj-10037	11	39	,	,	PUNCT
ecj-10037	11	40	florence	florence	NOUN
ecj-10037	11	41	,	,	PUNCT
ecj-10037	11	42	italy	italy	PROPN
ecj-10037	11	43	.	.	PUNCT
ecj-10037	12	1	tel	tel	PROPN
ecj-10037	12	2	.	.	PUNCT
ecj-10037	12	3	:	:	PUNCT
ecj-10037	13	1	+39.055.7946244	+39.055.7946244	PUNCT
ecj-10037	13	2	e	e	NOUN
ecj-10037	13	3	-	-	NOUN
ecj-10037	13	4	mail	mail	NOUN
ecj-10037	13	5	:	:	PUNCT
ecj-10037	13	6	simone.sartori@unifi.it	simone.sartori@unifi.it	VERB
ecj-10037	13	7	key	key	ADJ
ecj-10037	13	8	words	word	NOUN
ecj-10037	13	9	:	:	PUNCT
ecj-10037	13	10	bupropion	bupropion	NOUN
ecj-10037	13	11	;	;	PUNCT
ecj-10037	13	12	abuse	abuse	NOUN
ecj-10037	13	13	;	;	PUNCT
ecj-10037	13	14	sniffing	sniffing	NOUN
ecj-10037	13	15	;	;	PUNCT
ecj-10037	13	16	intoxication	intoxication	NOUN
ecj-10037	13	17	;	;	PUNCT
ecj-10037	13	18	case	case	NOUN
ecj-10037	13	19	report	report	NOUN
ecj-10037	13	20	.	.	PUNCT
ecj-10037	14	1	contribution	contribution	NOUN
ecj-10037	14	2	:	:	PUNCT
ecj-10037	14	3	all	all	DET
ecj-10037	14	4	authors	author	NOUN
ecj-10037	14	5	equally	equally	ADV
ecj-10037	14	6	contributed	contribute	VERB
ecj-10037	14	7	in	in	ADP
ecj-10037	14	8	the	the	DET
ecj-10037	14	9	development	development	NOUN
ecj-10037	14	10	of	of	ADP
ecj-10037	14	11	this	this	DET
ecj-10037	14	12	paper	paper	NOUN
ecj-10037	14	13	.	.	PUNCT
ecj-10037	15	1	ss	ss	PROPN
ecj-10037	15	2	,	,	PUNCT
ecj-10037	15	3	vb	vb	NOUN
ecj-10037	15	4	,	,	PUNCT
ecj-10037	15	5	lp	lp	NOUN
ecj-10037	15	6	,	,	PUNCT
ecj-10037	15	7	es	es	NOUN
ecj-10037	15	8	and	and	CCONJ
ecj-10037	15	9	mgdm	mgdm	NOUN
ecj-10037	15	10	collected	collect	VERB
ecj-10037	15	11	data	datum	NOUN
ecj-10037	15	12	.	.	PUNCT
ecj-10037	16	1	ss	ss	NOUN
ecj-10037	17	1	and	and	CCONJ
ecj-10037	17	2	fg	fg	PROPN
ecj-10037	17	3	initiated	initiate	VERB
ecj-10037	17	4	the	the	DET
ecj-10037	17	5	idea	idea	NOUN
ecj-10037	17	6	.	.	PUNCT
ecj-10037	18	1	ss	ss	PROPN
ecj-10037	18	2	performed	perform	VERB
ecj-10037	18	3	a	a	DET
ecj-10037	18	4	literature	literature	NOUN
ecj-10037	18	5	search	search	NOUN
ecj-10037	18	6	and	and	CCONJ
ecj-10037	18	7	wrote	write	VERB
ecj-10037	18	8	the	the	DET
ecj-10037	18	9	paper	paper	NOUN
ecj-10037	18	10	.	.	PUNCT
ecj-10037	19	1	vb	vb	NOUN
ecj-10037	19	2	helped	help	VERB
ecj-10037	19	3	with	with	ADP
ecj-10037	19	4	writing	write	VERB
ecj-10037	19	5	the	the	DET
ecj-10037	19	6	paper	paper	NOUN
ecj-10037	19	7	.	.	PUNCT
ecj-10037	20	1	cl	cl	NOUN
ecj-10037	20	2	,	,	PUNCT
ecj-10037	20	3	fg	fg	PROPN
ecj-10037	20	4	and	and	CCONJ
ecj-10037	20	5	mg	mg	PROPN
ecj-10037	20	6	reviewed	review	VERB
ecj-10037	20	7	the	the	DET
ecj-10037	20	8	manuscript	manuscript	NOUN
ecj-10037	20	9	.	.	PUNCT
ecj-10037	21	1	mg	mg	PROPN
ecj-10037	21	2	acts	act	VERB
ecj-10037	21	3	as	as	ADP
ecj-10037	21	4	the	the	DET
ecj-10037	21	5	guarantor	guarantor	NOUN
ecj-10037	21	6	of	of	ADP
ecj-10037	21	7	the	the	DET
ecj-10037	21	8	paper	paper	NOUN
ecj-10037	21	9	.	.	PUNCT
ecj-10037	22	1	conflict	conflict	NOUN
ecj-10037	22	2	of	of	ADP
ecj-10037	22	3	interest	interest	NOUN
ecj-10037	22	4	:	:	PUNCT
ecj-10037	22	5	the	the	DET
ecj-10037	22	6	authors	author	NOUN
ecj-10037	22	7	declare	declare	VERB
ecj-10037	22	8	no	no	DET
ecj-10037	22	9	conflict	conflict	NOUN
ecj-10037	22	10	of	of	ADP
ecj-10037	22	11	interests	interest	NOUN
ecj-10037	22	12	.	.	PUNCT
ecj-10037	23	1	availability	availability	NOUN
ecj-10037	23	2	of	of	ADP
ecj-10037	23	3	data	datum	NOUN
ecj-10037	23	4	and	and	CCONJ
ecj-10037	23	5	materials	material	NOUN
ecj-10037	23	6	:	:	PUNCT
ecj-10037	23	7	all	all	DET
ecj-10037	23	8	data	datum	NOUN
ecj-10037	23	9	underlying	underlie	VERB
ecj-10037	23	10	the	the	DET
ecj-10037	23	11	findings	finding	NOUN
ecj-10037	23	12	are	be	AUX
ecj-10037	23	13	fully	fully	ADV
ecj-10037	23	14	available	available	ADJ
ecj-10037	23	15	from	from	ADP
ecj-10037	23	16	the	the	DET
ecj-10037	23	17	corresponding	corresponding	ADJ
ecj-10037	23	18	author	author	NOUN
ecj-10037	23	19	upon	upon	SCONJ
ecj-10037	23	20	reasonable	reasonable	ADJ
ecj-10037	23	21	request	request	NOUN
ecj-10037	23	22	.	.	PUNCT
ecj-10037	24	1	ethics	ethic	NOUN
ecj-10037	24	2	approval	approval	NOUN
ecj-10037	24	3	and	and	CCONJ
ecj-10037	24	4	consent	consent	NOUN
ecj-10037	24	5	to	to	PART
ecj-10037	24	6	participate	participate	VERB
ecj-10037	24	7	:	:	PUNCT
ecj-10037	24	8	no	no	DET
ecj-10037	24	9	ethical	ethical	ADJ
ecj-10037	24	10	committee	committee	NOUN
ecj-10037	24	11	approval	approval	NOUN
ecj-10037	24	12	was	be	AUX
ecj-10037	24	13	required	require	VERB
ecj-10037	24	14	for	for	ADP
ecj-10037	24	15	this	this	DET
ecj-10037	24	16	case	case	NOUN
ecj-10037	24	17	report	report	NOUN
ecj-10037	24	18	by	by	ADP
ecj-10037	24	19	the	the	DET
ecj-10037	24	20	department	department	NOUN
ecj-10037	24	21	,	,	PUNCT
ecj-10037	24	22	because	because	SCONJ
ecj-10037	24	23	this	this	DET
ecj-10037	24	24	article	article	NOUN
ecj-10037	24	25	does	do	AUX
ecj-10037	24	26	not	not	PART
ecj-10037	24	27	contain	contain	VERB
ecj-10037	24	28	any	any	DET
ecj-10037	24	29	clinical	clinical	ADJ
ecj-10037	24	30	studies	study	NOUN
ecj-10037	24	31	with	with	ADP
ecj-10037	24	32	human	human	ADJ
ecj-10037	24	33	participants	participant	NOUN
ecj-10037	24	34	or	or	CCONJ
ecj-10037	24	35	animals	animal	NOUN
ecj-10037	24	36	.	.	PUNCT
ecj-10037	25	1	consent	consent	NOUN
ecj-10037	25	2	for	for	ADP
ecj-10037	25	3	publication	publication	NOUN
ecj-10037	25	4	:	:	PUNCT
ecj-10037	25	5	not	not	PART
ecj-10037	25	6	applicable	applicable	ADJ
ecj-10037	25	7	.	.	PUNCT
ecj-10037	26	1	the	the	DET
ecj-10037	26	2	evaluation	evaluation	NOUN
ecj-10037	26	3	of	of	ADP
ecj-10037	26	4	the	the	DET
ecj-10037	26	5	case	case	NOUN
ecj-10037	26	6	was	be	AUX
ecj-10037	26	7	performed	perform	VERB
ecj-10037	26	8	using	use	VERB
ecj-10037	26	9	anonymized	anonymize	VERB
ecj-10037	26	10	patient	patient	ADJ
ecj-10037	26	11	data	datum	NOUN
ecj-10037	26	12	,	,	PUNCT
ecj-10037	26	13	therefore	therefore	ADV
ecj-10037	26	14	without	without	ADP
ecj-10037	26	15	the	the	DET
ecj-10037	26	16	need	need	NOUN
ecj-10037	26	17	for	for	ADP
ecj-10037	26	18	patient	patient	ADJ
ecj-10037	26	19	consent	consent	NOUN
ecj-10037	26	20	.	.	PUNCT
ecj-10037	27	1	received	receive	VERB
ecj-10037	27	2	for	for	ADP
ecj-10037	27	3	publication	publication	NOUN
ecj-10037	27	4	:	:	PUNCT
ecj-10037	27	5	13	13	NUM
ecj-10037	27	6	august	august	PROPN
ecj-10037	27	7	2021	2021	NUM
ecj-10037	27	8	.	.	PUNCT
ecj-10037	28	1	revision	revision	NOUN
ecj-10037	28	2	received	receive	VERB
ecj-10037	28	3	:	:	PUNCT
ecj-10037	28	4	4	4	NUM
ecj-10037	28	5	december	december	PROPN
ecj-10037	28	6	2021	2021	NUM
ecj-10037	28	7	.	.	PUNCT
ecj-10037	29	1	accepted	accept	VERB
ecj-10037	29	2	for	for	ADP
ecj-10037	29	3	publication	publication	NOUN
ecj-10037	29	4	:	:	PUNCT
ecj-10037	29	5	6	6	NUM
ecj-10037	29	6	december	december	PROPN
ecj-10037	29	7	2021	2021	NUM
ecj-10037	29	8	.	.	PUNCT
ecj-10037	30	1	this	this	DET
ecj-10037	30	2	work	work	NOUN
ecj-10037	30	3	is	be	AUX
ecj-10037	30	4	licensed	license	VERB
ecj-10037	30	5	under	under	ADP
ecj-10037	30	6	a	a	DET
ecj-10037	30	7	creative	creative	ADJ
ecj-10037	30	8	commons	common	NOUN
ecj-10037	30	9	attribution	attribution	NOUN
ecj-10037	30	10	4.0	4.0	NUM
ecj-10037	30	11	license	license	NOUN
ecj-10037	30	12	(	(	PUNCT
ecj-10037	30	13	by	by	ADP
ecj-10037	30	14	-	-	PUNCT
ecj-10037	30	15	nc	nc	PROPN
ecj-10037	30	16	4.0	4.0	NUM
ecj-10037	30	17	)	)	PUNCT
ecj-10037	30	18	.	.	PUNCT
ecj-10037	31	1	©	©	PROPN
ecj-10037	31	2	copyright	copyright	NOUN
ecj-10037	31	3	:	:	PUNCT
ecj-10037	31	4	the	the	DET
ecj-10037	31	5	author(s	author(s	PROPN
ecj-10037	31	6	)	)	PUNCT
ecj-10037	31	7	,	,	PUNCT
ecj-10037	31	8	2021	2021	NUM
ecj-10037	31	9	licensee	licensee	NOUN
ecj-10037	31	10	pagepress	pagepress	NOUN
ecj-10037	31	11	,	,	PUNCT
ecj-10037	31	12	italy	italy	PROPN
ecj-10037	31	13	emergency	emergency	PROPN
ecj-10037	31	14	care	care	PROPN
ecj-10037	31	15	journal	journal	PROPN
ecj-10037	31	16	2021	2021	NUM
ecj-10037	31	17	;	;	PUNCT
ecj-10037	31	18	17:10037	17:10037	NUM
ecj-10037	31	19	doi:10.4081	doi:10.4081	NOUN
ecj-10037	31	20	/	/	SYM
ecj-10037	31	21	ecj.2021.10037	ecj.2021.10037	NUM
ecj-10037	31	22	[	[	X
ecj-10037	31	23	emergency	emergency	NOUN
ecj-10037	31	24	care	care	NOUN
ecj-10037	31	25	journal	journal	PROPN
ecj-10037	31	26	2021	2021	NUM
ecj-10037	31	27	;	;	PUNCT
ecj-10037	31	28	17:10037	17:10037	NUM
ecj-10037	31	29	]	]	X
ecj-10037	32	1	[	[	X
ecj-10037	32	2	page	page	NOUN
ecj-10037	32	3	45	45	NUM
ecj-10037	32	4	]	]	PUNCT
ecj-10037	32	5	acute	acute	ADJ
ecj-10037	32	6	intoxication	intoxication	NOUN
ecj-10037	32	7	following	follow	VERB
ecj-10037	32	8	massive	massive	ADJ
ecj-10037	32	9	bupropion	bupropion	NOUN
ecj-10037	32	10	sniffing	sniffing	NOUN
ecj-10037	32	11	:	:	PUNCT
ecj-10037	32	12	a	a	DET
ecj-10037	32	13	case	case	NOUN
ecj-10037	32	14	report	report	VERB
ecj-10037	32	15	simone	simone	PROPN
ecj-10037	32	16	sartori,1	sartori,1	PROPN
ecj-10037	32	17	valentina	valentina	PROPN
ecj-10037	32	18	brilli,1	brilli,1	PROPN
ecj-10037	32	19	cecilia	cecilia	PROPN
ecj-10037	32	20	lanzi,2	lanzi,2	PROPN
ecj-10037	32	21	luca	luca	PROPN
ecj-10037	32	22	pratticò,3	pratticò,3	PROPN
ecj-10037	32	23	elisabetta	elisabetta	PROPN
ecj-10037	32	24	sarcoli,3	sarcoli,3	PROPN
ecj-10037	32	25	maria	maria	PROPN
ecj-10037	32	26	grazia	grazia	PROPN
ecj-10037	32	27	di	di	PROPN
ecj-10037	32	28	milia,4	milia,4	PROPN
ecj-10037	32	29	francesco	francesco	PROPN
ecj-10037	32	30	gambassi,2	gambassi,2	PROPN
ecj-10037	32	31	guido	guido	NOUN
ecj-10037	32	32	mannaioni1,2	mannaioni1,2	PROPN
ecj-10037	32	33	1department	1department	NUM
ecj-10037	32	34	of	of	ADP
ecj-10037	32	35	neurosciences	neuroscience	NOUN
ecj-10037	32	36	,	,	PUNCT
ecj-10037	32	37	psychology	psychology	NOUN
ecj-10037	32	38	,	,	PUNCT
ecj-10037	32	39	drug	drug	NOUN
ecj-10037	32	40	research	research	NOUN
ecj-10037	32	41	and	and	CCONJ
ecj-10037	32	42	child	child	NOUN
ecj-10037	32	43	health	health	NOUN
ecj-10037	32	44	,	,	PUNCT
ecj-10037	32	45	section	section	NOUN
ecj-10037	32	46	of	of	ADP
ecj-10037	32	47	pharmacology	pharmacology	NOUN
ecj-10037	32	48	and	and	CCONJ
ecj-10037	32	49	toxicology	toxicology	NOUN
ecj-10037	32	50	,	,	PUNCT
ecj-10037	32	51	university	university	NOUN
ecj-10037	32	52	of	of	ADP
ecj-10037	32	53	florence	florence	NOUN
ecj-10037	32	54	,	,	PUNCT
ecj-10037	32	55	florence	florence	NOUN
ecj-10037	32	56	;	;	PUNCT
ecj-10037	32	57	2medical	2medical	NUM
ecj-10037	32	58	toxicology	toxicology	NOUN
ecj-10037	32	59	unit	unit	NOUN
ecj-10037	32	60	and	and	CCONJ
ecj-10037	32	61	poison	poison	NOUN
ecj-10037	32	62	control	control	NOUN
ecj-10037	32	63	centre	centre	PROPN
ecj-10037	32	64	,	,	PUNCT
ecj-10037	32	65	careggi	careggi	PROPN
ecj-10037	32	66	university	university	NOUN
ecj-10037	32	67	hospital	hospital	NOUN
ecj-10037	32	68	,	,	PUNCT
ecj-10037	32	69	florence	florence	NOUN
ecj-10037	32	70	;	;	PUNCT
ecj-10037	32	71	3emergency	3emergency	NUM
ecj-10037	32	72	department	department	NOUN
ecj-10037	32	73	,	,	PUNCT
ecj-10037	32	74	azienda	azienda	PROPN
ecj-10037	32	75	usl	usl	PROPN
ecj-10037	32	76	toscana	toscana	PROPN
ecj-10037	32	77	sud	sud	PROPN
ecj-10037	32	78	est	est	PROPN
ecj-10037	32	79	,	,	PUNCT
ecj-10037	32	80	grosseto	grosseto	PROPN
ecj-10037	32	81	;	;	PUNCT
ecj-10037	32	82	4forensic	4forensic	NUM
ecj-10037	32	83	toxicology	toxicology	NOUN
ecj-10037	32	84	unit	unit	NOUN
ecj-10037	32	85	,	,	PUNCT
ecj-10037	32	86	medical	medical	ADJ
ecj-10037	32	87	toxicology	toxicology	NOUN
ecj-10037	32	88	unit	unit	NOUN
ecj-10037	32	89	and	and	CCONJ
ecj-10037	32	90	poison	poison	NOUN
ecj-10037	32	91	control	control	NOUN
ecj-10037	32	92	centre	centre	PROPN
ecj-10037	32	93	,	,	PUNCT
ecj-10037	32	94	careggi	careggi	PROPN
ecj-10037	32	95	university	university	NOUN
ecj-10037	32	96	hospital	hospital	NOUN
ecj-10037	32	97	,	,	PUNCT
ecj-10037	32	98	florence	florence	NOUN
ecj-10037	32	99	,	,	PUNCT
ecj-10037	32	100	italy	italy	PROPN
ecj-10037	32	101	non	non	PROPN
ecj-10037	32	102	-co	-co	PROPN
ecj-10037	32	103	mmerc	mmerc	PROPN
ecj-10037	32	104	ial	ial	PROPN
ecj-10037	32	105	us	us	PROPN
ecj-10037	32	106	e	e	NOUN
ecj-10037	32	107	o	o	PUNCT
ecj-10037	32	108	nly	nly	ADV
ecj-10037	32	109	chotherapy	chotherapy	NOUN
ecj-10037	32	110	and	and	CCONJ
ecj-10037	32	111	bupropion	bupropion	NOUN
ecj-10037	32	112	(	(	PUNCT
ecj-10037	32	113	unknown	unknown	ADJ
ecj-10037	32	114	formulation	formulation	NOUN
ecj-10037	32	115	dosage	dosage	NOUN
ecj-10037	32	116	)	)	PUNCT
ecj-10037	32	117	besides	besides	SCONJ
ecj-10037	32	118	a	a	DET
ecj-10037	32	119	previously	previously	ADV
ecj-10037	32	120	diagnosed	diagnose	VERB
ecj-10037	32	121	cocaine	cocaine	NOUN
ecj-10037	32	122	use	use	NOUN
ecj-10037	32	123	disorder	disorder	NOUN
ecj-10037	32	124	.	.	PUNCT
ecj-10037	33	1	mental	mental	ADJ
ecj-10037	33	2	confusion	confusion	NOUN
ecj-10037	33	3	,	,	PUNCT
ecj-10037	33	4	hypertension	hypertension	NOUN
ecj-10037	33	5	,	,	PUNCT
ecj-10037	33	6	deep	deep	ADJ
ecj-10037	33	7	tendon	tendon	NOUN
ecj-10037	33	8	hyperreflexia	hyperreflexia	NOUN
ecj-10037	33	9	and	and	CCONJ
ecj-10037	33	10	dry	dry	ADJ
ecj-10037	33	11	mouth	mouth	NOUN
ecj-10037	33	12	were	be	AUX
ecj-10037	33	13	present	present	ADJ
ecj-10037	33	14	at	at	ADP
ecj-10037	33	15	medical	medical	ADJ
ecj-10037	33	16	examination	examination	NOUN
ecj-10037	33	17	while	while	SCONJ
ecj-10037	33	18	electrocardiogram	electrocardiogram	NOUN
ecj-10037	33	19	(	(	PUNCT
ecj-10037	33	20	ecg	ecg	PROPN
ecj-10037	33	21	)	)	PUNCT
ecj-10037	33	22	at	at	ADP
ecj-10037	33	23	arrival	arrival	NOUN
ecj-10037	33	24	showed	show	VERB
ecj-10037	33	25	sinus	sinus	NOUN
ecj-10037	33	26	tachycardia	tachycardia	NOUN
ecj-10037	33	27	with	with	ADP
ecj-10037	33	28	a	a	DET
ecj-10037	33	29	484	484	NUM
ecj-10037	33	30	msec	msec	NOUN
ecj-10037	33	31	corrected	correct	VERB
ecj-10037	33	32	qt	qt	NOUN
ecj-10037	33	33	interval	interval	NOUN
ecj-10037	33	34	(	(	PUNCT
ecj-10037	33	35	qtc	qtc	PROPN
ecj-10037	33	36	)	)	PUNCT
ecj-10037	33	37	prolongation	prolongation	NOUN
ecj-10037	33	38	(	(	PUNCT
ecj-10037	33	39	figure	figure	NOUN
ecj-10037	33	40	1	1	NUM
ecj-10037	33	41	)	)	PUNCT
ecj-10037	33	42	.	.	PUNCT
ecj-10037	34	1	no	no	DET
ecj-10037	34	2	qrs	qrs	PROPN
ecj-10037	34	3	complex	complex	ADJ
ecj-10037	34	4	alteration	alteration	NOUN
ecj-10037	34	5	was	be	AUX
ecj-10037	34	6	present	present	ADJ
ecj-10037	34	7	.	.	PUNCT
ecj-10037	35	1	the	the	DET
ecj-10037	35	2	above	above	ADV
ecj-10037	35	3	-	-	PUNCT
ecj-10037	35	4	mentioned	mention	VERB
ecj-10037	35	5	findings	finding	NOUN
ecj-10037	35	6	were	be	AUX
ecj-10037	35	7	compatible	compatible	ADJ
ecj-10037	35	8	with	with	ADP
ecj-10037	35	9	the	the	DET
ecj-10037	35	10	suspected	suspect	VERB
ecj-10037	35	11	intoxication	intoxication	NOUN
ecj-10037	35	12	.	.	PUNCT
ecj-10037	36	1	a	a	DET
ecj-10037	36	2	toxicology	toxicology	NOUN
ecj-10037	36	3	consultation	consultation	NOUN
ecj-10037	36	4	was	be	AUX
ecj-10037	36	5	requested	request	VERB
ecj-10037	36	6	and	and	CCONJ
ecj-10037	36	7	poison	poison	NOUN
ecj-10037	36	8	control	control	NOUN
ecj-10037	36	9	centre	centre	PROPN
ecj-10037	36	10	(	(	PUNCT
ecj-10037	36	11	pcc	pcc	NOUN
ecj-10037	36	12	)	)	PUNCT
ecj-10037	36	13	suggested	suggest	VERB
ecj-10037	36	14	cardiac	cardiac	ADJ
ecj-10037	36	15	monitoring	monitoring	NOUN
ecj-10037	36	16	in	in	ADP
ecj-10037	36	17	addition	addition	NOUN
ecj-10037	36	18	to	to	ADP
ecj-10037	36	19	iv	iv	NUM
ecj-10037	36	20	rehydration	rehydration	NOUN
ecj-10037	36	21	.	.	PUNCT
ecj-10037	37	1	given	give	VERB
ecj-10037	37	2	the	the	DET
ecj-10037	37	3	risk	risk	NOUN
ecj-10037	37	4	of	of	ADP
ecj-10037	37	5	hyper	hyper	ADJ
ecj-10037	37	6	-	-	PUNCT
ecj-10037	37	7	activation	activation	NOUN
ecj-10037	37	8	status	status	NOUN
ecj-10037	37	9	,	,	PUNCT
ecj-10037	37	10	possible	possible	ADJ
ecj-10037	37	11	seizures	seizure	NOUN
ecj-10037	37	12	and	and	CCONJ
ecj-10037	37	13	serotonin	serotonin	VERB
ecj-10037	37	14	syndrome	syndrome	NOUN
ecj-10037	37	15	due	due	ADP
ecj-10037	37	16	to	to	ADP
ecj-10037	37	17	the	the	DET
ecj-10037	37	18	hypothetical	hypothetical	ADJ
ecj-10037	37	19	high	high	ADJ
ecj-10037	37	20	amount	amount	NOUN
ecj-10037	37	21	of	of	ADP
ecj-10037	37	22	absorbed	absorb	VERB
ecj-10037	37	23	bupropion	bupropion	NOUN
ecj-10037	37	24	,	,	PUNCT
ecj-10037	37	25	lorazepam	lorazepam	PROPN
ecj-10037	37	26	(	(	PUNCT
ecj-10037	37	27	4	4	NUM
ecj-10037	37	28	mg	mg	NOUN
ecj-10037	37	29	iv	iv	NUM
ecj-10037	37	30	)	)	PUNCT
ecj-10037	37	31	was	be	AUX
ecj-10037	37	32	administered	administer	VERB
ecj-10037	37	33	.	.	PUNCT
ecj-10037	38	1	subsequent	subsequent	ADJ
ecj-10037	38	2	electroencephalogram	electroencephalogram	NOUN
ecj-10037	38	3	(	(	PUNCT
ecj-10037	38	4	eeg	eeg	NOUN
ecj-10037	38	5	)	)	PUNCT
ecj-10037	38	6	and	and	CCONJ
ecj-10037	38	7	ct	ct	PROPN
ecj-10037	38	8	-	-	PUNCT
ecj-10037	38	9	scan	scan	PROPN
ecj-10037	38	10	ruled	rule	VERB
ecj-10037	38	11	out	out	ADP
ecj-10037	38	12	any	any	DET
ecj-10037	38	13	evidence	evidence	NOUN
ecj-10037	38	14	of	of	ADP
ecj-10037	38	15	neurologic	neurologic	ADJ
ecj-10037	38	16	impairment	impairment	NOUN
ecj-10037	38	17	(	(	PUNCT
ecj-10037	38	18	epileptic	epileptic	ADJ
ecj-10037	38	19	patterns	pattern	NOUN
ecj-10037	38	20	,	,	PUNCT
ecj-10037	38	21	parenchymal	parenchymal	ADJ
ecj-10037	38	22	lesions	lesion	NOUN
ecj-10037	38	23	and	and	CCONJ
ecj-10037	38	24	blood	blood	NOUN
ecj-10037	38	25	extravasation	extravasation	NOUN
ecj-10037	38	26	)	)	PUNCT
ecj-10037	38	27	due	due	ADP
ecj-10037	38	28	to	to	ADP
ecj-10037	38	29	acute	acute	ADJ
ecj-10037	38	30	bupropion	bupropion	NOUN
ecj-10037	38	31	intoxication	intoxication	NOUN
ecj-10037	38	32	.	.	PUNCT
ecj-10037	39	1	a	a	DET
ecj-10037	39	2	toxicological	toxicological	ADJ
ecj-10037	39	3	urine	urine	NOUN
ecj-10037	39	4	screening	screening	NOUN
ecj-10037	39	5	was	be	AUX
ecj-10037	39	6	performed	perform	VERB
ecj-10037	39	7	with	with	ADP
ecj-10037	39	8	resulting	result	VERB
ecj-10037	39	9	positivity	positivity	NOUN
ecj-10037	39	10	only	only	ADV
ecj-10037	39	11	for	for	ADP
ecj-10037	39	12	bzd	bzd	NOUN
ecj-10037	39	13	,	,	PUNCT
ecj-10037	39	14	whereas	whereas	SCONJ
ecj-10037	39	15	only	only	ADV
ecj-10037	39	16	mild	mild	ADJ
ecj-10037	39	17	leukocytosis	leukocytosis	NOUN
ecj-10037	39	18	was	be	AUX
ecj-10037	39	19	detected	detect	VERB
ecj-10037	39	20	at	at	ADP
ecj-10037	39	21	blood	blood	NOUN
ecj-10037	39	22	test	test	NOUN
ecj-10037	39	23	(	(	PUNCT
ecj-10037	39	24	15.23	15.23	NUM
ecj-10037	39	25	x103	x103	PROPN
ecj-10037	39	26	/	/	SYM
ecj-10037	39	27	ul	ul	PROPN
ecj-10037	39	28	with	with	ADP
ecj-10037	39	29	normal	normal	ADJ
ecj-10037	39	30	range	range	NOUN
ecj-10037	39	31	3.5	3.5	NUM
ecj-10037	39	32	-	-	SYM
ecj-10037	39	33	9.5	9.5	NUM
ecj-10037	39	34	)	)	PUNCT
ecj-10037	39	35	.	.	PUNCT
ecj-10037	40	1	clinical	clinical	ADJ
ecj-10037	40	2	signs	sign	NOUN
ecj-10037	40	3	and	and	CCONJ
ecj-10037	40	4	symptoms	symptom	NOUN
ecj-10037	40	5	of	of	ADP
ecj-10037	40	6	intoxication	intoxication	NOUN
ecj-10037	40	7	normalized	normalize	VERB
ecj-10037	40	8	after	after	ADP
ecj-10037	40	9	27	27	NUM
ecj-10037	40	10	hours	hour	NOUN
ecj-10037	40	11	of	of	ADP
ecj-10037	40	12	observation	observation	NOUN
ecj-10037	40	13	without	without	ADP
ecj-10037	40	14	any	any	DET
ecj-10037	40	15	complication	complication	NOUN
ecj-10037	40	16	.	.	PUNCT
ecj-10037	41	1	the	the	DET
ecj-10037	41	2	patient	patient	NOUN
ecj-10037	41	3	decided	decide	VERB
ecj-10037	41	4	to	to	PART
ecj-10037	41	5	self	self	NOUN
ecj-10037	41	6	-	-	PUNCT
ecj-10037	41	7	discharge	discharge	NOUN
ecj-10037	41	8	after	after	ADP
ecj-10037	41	9	a	a	DET
ecj-10037	41	10	psychiatric	psychiatric	ADJ
ecj-10037	41	11	consultation	consultation	NOUN
ecj-10037	41	12	,	,	PUNCT
ecj-10037	41	13	being	be	AUX
ecj-10037	41	14	therefore	therefore	ADV
ecj-10037	41	15	referred	refer	VERB
ecj-10037	41	16	to	to	ADP
ecj-10037	41	17	his	his	PRON
ecj-10037	41	18	psychotherapist	psychotherapist	NOUN
ecj-10037	41	19	.	.	PUNCT
ecj-10037	42	1	to	to	PART
ecj-10037	42	2	certify	certify	VERB
ecj-10037	42	3	the	the	DET
ecj-10037	42	4	reported	report	VERB
ecj-10037	42	5	intake	intake	NOUN
ecj-10037	42	6	of	of	ADP
ecj-10037	42	7	bupropion	bupropion	NOUN
ecj-10037	42	8	,	,	PUNCT
ecj-10037	42	9	blood	blood	NOUN
ecj-10037	42	10	and	and	CCONJ
ecj-10037	42	11	urine	urine	NOUN
ecj-10037	42	12	samples	sample	NOUN
ecj-10037	42	13	were	be	AUX
ecj-10037	42	14	taken	take	VERB
ecj-10037	42	15	18	18	NUM
ecj-10037	42	16	hours	hour	NOUN
ecj-10037	42	17	after	after	ADP
ecj-10037	42	18	the	the	DET
ecj-10037	42	19	event	event	NOUN
ecj-10037	42	20	in	in	ADP
ecj-10037	42	21	order	order	NOUN
ecj-10037	42	22	to	to	PART
ecj-10037	42	23	perform	perform	VERB
ecj-10037	42	24	a	a	DET
ecj-10037	42	25	second	second	ADJ
ecj-10037	42	26	-	-	PUNCT
ecj-10037	42	27	level	level	NOUN
ecj-10037	42	28	investigation	investigation	NOUN
ecj-10037	42	29	with	with	ADP
ecj-10037	42	30	gas	gas	NOUN
ecj-10037	42	31	chromatography	chromatography	NOUN
ecj-10037	42	32	-	-	PUNCT
ecj-10037	42	33	mass	mass	NOUN
ecj-10037	42	34	spectrometry	spectrometry	NOUN
ecj-10037	42	35	(	(	PUNCT
ecj-10037	42	36	gc	gc	PROPN
ecj-10037	42	37	-	-	PUNCT
ecj-10037	42	38	ms	ms	NOUN
ecj-10037	42	39	)	)	PUNCT
ecj-10037	42	40	.	.	PUNCT
ecj-10037	43	1	bupropion	bupropion	PROPN
ecj-10037	43	2	serum	serum	PROPN
ecj-10037	43	3	and	and	CCONJ
ecj-10037	43	4	urine	urine	NOUN
ecj-10037	43	5	concentration	concentration	NOUN
ecj-10037	43	6	levels	level	NOUN
ecj-10037	43	7	were	be	AUX
ecj-10037	43	8	1905.26	1905.26	NUM
ecj-10037	43	9	and	and	CCONJ
ecj-10037	43	10	2001.57	2001.57	NUM
ecj-10037	43	11	ng	ng	PROPN
ecj-10037	43	12	/	/	SYM
ecj-10037	43	13	ml	ml	PROPN
ecj-10037	43	14	,	,	PUNCT
ecj-10037	43	15	respectively	respectively	ADV
ecj-10037	43	16	(	(	PUNCT
ecj-10037	43	17	figure	figure	NOUN
ecj-10037	43	18	2	2	NUM
ecj-10037	43	19	)	)	PUNCT
ecj-10037	43	20	.	.	PUNCT
ecj-10037	44	1	urine	urine	NOUN
ecj-10037	44	2	toxicological	toxicological	ADJ
ecj-10037	44	3	screening	screening	NOUN
ecj-10037	44	4	and	and	CCONJ
ecj-10037	44	5	clinical	clinical	ADJ
ecj-10037	44	6	monitoring	monitoring	NOUN
ecj-10037	44	7	of	of	ADP
ecj-10037	44	8	vital	vital	ADJ
ecj-10037	44	9	signs	sign	NOUN
ecj-10037	44	10	throughout	throughout	ADP
ecj-10037	44	11	hospitalization	hospitalization	NOUN
ecj-10037	44	12	are	be	AUX
ecj-10037	44	13	summarized	summarize	VERB
ecj-10037	44	14	in	in	ADP
ecj-10037	44	15	table	table	NOUN
ecj-10037	44	16	1	1	NUM
ecj-10037	44	17	.	.	PUNCT
ecj-10037	45	1	discussion	discussion	NOUN
ecj-10037	45	2	this	this	DET
ecj-10037	45	3	case	case	NOUN
ecj-10037	45	4	of	of	ADP
ecj-10037	45	5	intranasal	intranasal	ADJ
ecj-10037	45	6	bupropion	bupropion	NOUN
ecj-10037	45	7	misuse	misuse	NOUN
ecj-10037	45	8	shared	share	VERB
ecj-10037	45	9	only	only	ADV
ecj-10037	45	10	some	some	PRON
ecj-10037	45	11	of	of	ADP
ecj-10037	45	12	the	the	DET
ecj-10037	45	13	most	most	ADV
ecj-10037	45	14	common	common	ADJ
ecj-10037	45	15	clinical	clinical	ADJ
ecj-10037	45	16	features	feature	NOUN
ecj-10037	45	17	of	of	ADP
ecj-10037	45	18	a	a	DET
ecj-10037	45	19	classical	classical	ADJ
ecj-10037	45	20	bupropion	bupropion	NOUN
ecj-10037	45	21	ingestion	ingestion	NOUN
ecj-10037	45	22	overdose	overdose	NOUN
ecj-10037	45	23	(	(	PUNCT
ecj-10037	45	24	considering	consider	VERB
ecj-10037	45	25	comparable	comparable	ADJ
ecj-10037	45	26	amounts	amount	NOUN
ecj-10037	45	27	of	of	ADP
ecj-10037	45	28	medication).14	medication).14	PROPN
ecj-10037	45	29	therapeutic	therapeutic	ADJ
ecj-10037	45	30	daily	daily	ADJ
ecj-10037	45	31	doses	dose	NOUN
ecj-10037	45	32	for	for	ADP
ecj-10037	45	33	bupropion	bupropion	NOUN
ecj-10037	45	34	are	be	AUX
ecj-10037	45	35	usually	usually	ADV
ecj-10037	45	36	up	up	ADP
ecj-10037	45	37	to	to	PART
ecj-10037	45	38	300	300	NUM
ecj-10037	45	39	mg	mg	NOUN
ecj-10037	45	40	/	/	SYM
ecj-10037	45	41	day15	day15	NOUN
ecj-10037	45	42	reaching	reach	VERB
ecj-10037	45	43	peak	peak	NOUN
ecj-10037	45	44	concentration	concentration	NOUN
ecj-10037	45	45	after	after	ADP
ecj-10037	45	46	1.5	1.5	NUM
ecj-10037	45	47	hours	hour	NOUN
ecj-10037	45	48	and	and	CCONJ
ecj-10037	45	49	3	3	NUM
ecj-10037	45	50	-	-	SYM
ecj-10037	45	51	5	5	NUM
ecj-10037	45	52	hours	hour	NOUN
ecj-10037	45	53	for	for	ADP
ecj-10037	45	54	immediate	immediate	ADJ
ecj-10037	45	55	or	or	CCONJ
ecj-10037	45	56	modified	modified	ADJ
ecj-10037	45	57	-	-	PUNCT
ecj-10037	45	58	release	release	NOUN
ecj-10037	45	59	formulations	formulation	NOUN
ecj-10037	45	60	,	,	PUNCT
ecj-10037	45	61	respectively.16	respectively.16	ADJ
ecj-10037	45	62	half	half	ADJ
ecj-10037	45	63	-	-	PUNCT
ecj-10037	45	64	life	life	NOUN
ecj-10037	45	65	is	be	AUX
ecj-10037	45	66	about	about	ADV
ecj-10037	45	67	21	21	NUM
ecj-10037	45	68	hours	hour	NOUN
ecj-10037	45	69	in	in	ADP
ecj-10037	45	70	chronic	chronic	ADJ
ecj-10037	45	71	users	user	NOUN
ecj-10037	45	72	and	and	CCONJ
ecj-10037	45	73	it	it	PRON
ecj-10037	45	74	can	can	AUX
ecj-10037	45	75	be	be	AUX
ecj-10037	45	76	even	even	ADV
ecj-10037	45	77	longer	long	ADJ
ecj-10037	45	78	for	for	ADP
ecj-10037	45	79	the	the	DET
ecj-10037	45	80	presence	presence	NOUN
ecj-10037	45	81	of	of	ADP
ecj-10037	45	82	active	active	ADJ
ecj-10037	45	83	metabolites.14	metabolites.14	NOUN
ecj-10037	45	84	therapeutic	therapeutic	ADJ
ecj-10037	45	85	window	window	NOUN
ecj-10037	45	86	is	be	AUX
ecj-10037	45	87	considered	consider	VERB
ecj-10037	45	88	between	between	ADP
ecj-10037	45	89	5	5	NUM
ecj-10037	45	90	to	to	PART
ecj-10037	45	91	100	100	NUM
ecj-10037	45	92	ng	ng	PROPN
ecj-10037	45	93	/	/	SYM
ecj-10037	45	94	ml.17	ml.17	PROPN
ecj-10037	45	95	although	although	SCONJ
ecj-10037	45	96	our	our	PRON
ecj-10037	45	97	patient	patient	NOUN
ecj-10037	45	98	’s	’s	PART
ecj-10037	45	99	bupropion	bupropion	NOUN
ecj-10037	45	100	dose	dose	NOUN
ecj-10037	45	101	formulation	formulation	NOUN
ecj-10037	45	102	was	be	AUX
ecj-10037	45	103	unknown	unknown	ADJ
ecj-10037	45	104	,	,	PUNCT
ecj-10037	45	105	only	only	ADV
ecj-10037	45	106	150	150	NUM
ecj-10037	45	107	mg	mg	NOUN
ecj-10037	45	108	and	and	CCONJ
ecj-10037	45	109	300	300	NUM
ecj-10037	45	110	mg	mg	NOUN
ecj-10037	45	111	modified	modify	VERB
ecj-10037	45	112	/	/	SYM
ecj-10037	45	113	sustained	sustain	VERB
ecj-10037	45	114	formulations	formulation	NOUN
ecj-10037	45	115	are	be	AUX
ecj-10037	45	116	available	available	ADJ
ecj-10037	45	117	on	on	ADP
ecj-10037	45	118	the	the	DET
ecj-10037	45	119	case	case	NOUN
ecj-10037	45	120	report	report	NOUN
ecj-10037	45	121	figure	figure	NOUN
ecj-10037	45	122	1	1	NUM
ecj-10037	45	123	.	.	PUNCT
ecj-10037	45	124	sinus	sinus	NOUN
ecj-10037	45	125	tachycardia	tachycardia	NOUN
ecj-10037	45	126	with	with	ADP
ecj-10037	45	127	125	125	NUM
ecj-10037	45	128	beats	beat	NOUN
ecj-10037	45	129	per	per	ADP
ecj-10037	45	130	minute	minute	NOUN
ecj-10037	45	131	heart	heart	NOUN
ecj-10037	45	132	rate	rate	NOUN
ecj-10037	45	133	and	and	CCONJ
ecj-10037	45	134	nonspecific	nonspecific	ADJ
ecj-10037	45	135	alterations	alteration	NOUN
ecj-10037	45	136	of	of	ADP
ecj-10037	45	137	ventricular	ventricular	ADJ
ecj-10037	45	138	repolarization.qtc	repolarization.qtc	NOUN
ecj-10037	45	139	prolongation	prolongation	NOUN
ecj-10037	45	140	(	(	PUNCT
ecj-10037	45	141	484	484	NUM
ecj-10037	45	142	msec	msec	NOUN
ecj-10037	45	143	)	)	PUNCT
ecj-10037	45	144	.	.	PUNCT
ecj-10037	46	1	figure	figure	NOUN
ecj-10037	46	2	2	2	NUM
ecj-10037	46	3	.	.	PUNCT
ecj-10037	46	4	bupropion	bupropion	NOUN
ecj-10037	46	5	serum	serum	PROPN
ecj-10037	46	6	and	and	CCONJ
ecj-10037	46	7	urine	urine	NOUN
ecj-10037	46	8	concentration	concentration	NOUN
ecj-10037	46	9	levels	level	NOUN
ecj-10037	46	10	at	at	ADP
ecj-10037	46	11	18hours	18hours	NUM
ecj-10037	46	12	from	from	ADP
ecj-10037	46	13	the	the	DET
ecj-10037	46	14	event	event	NOUN
ecj-10037	46	15	.	.	PUNCT
ecj-10037	47	1	table	table	NOUN
ecj-10037	47	2	1	1	NUM
ecj-10037	47	3	.	.	PUNCT
ecj-10037	48	1	patients	patient	NOUN
ecj-10037	48	2	vitals	vital	NOUN
ecj-10037	48	3	and	and	CCONJ
ecj-10037	48	4	laboratory	laboratory	NOUN
ecj-10037	48	5	screening	screening	NOUN
ecj-10037	48	6	during	during	ADP
ecj-10037	48	7	hospitalization	hospitalization	NOUN
ecj-10037	48	8	.	.	PUNCT
ecj-10037	49	1	vitals	vital	NOUN
ecj-10037	49	2	day	day	NOUN
ecj-10037	49	3	1	1	NUM
ecj-10037	49	4	12:42	12:42	NUM
ecj-10037	49	5	pm	pm	NOUN
ecj-10037	49	6	day	day	NOUN
ecj-10037	49	7	1	1	NUM
ecj-10037	49	8	01:41	01:41	NUM
ecj-10037	49	9	pm	pm	NOUN
ecj-10037	49	10	day	day	NOUN
ecj-10037	49	11	1	1	NUM
ecj-10037	49	12	02:24	02:24	NUM
ecj-10037	49	13	pm	pm	NOUN
ecj-10037	49	14	day	day	NOUN
ecj-10037	49	15	1	1	NUM
ecj-10037	49	16	02:26	02:26	NUM
ecj-10037	49	17	pm	pm	NOUN
ecj-10037	49	18	day	day	NOUN
ecj-10037	49	19	1	1	NUM
ecj-10037	49	20	09:46	09:46	NUM
ecj-10037	49	21	pmday	pmday	NOUN
ecj-10037	49	22	2	2	NUM
ecj-10037	49	23	10:06	10:06	NUM
ecj-10037	49	24	am	am	NOUN
ecj-10037	49	25	day	day	NOUN
ecj-10037	49	26	2	2	NUM
ecj-10037	49	27	14:41	14:41	NUM
ecj-10037	49	28	pm	pm	NOUN
ecj-10037	49	29	hr	hr	NOUN
ecj-10037	49	30	(	(	PUNCT
ecj-10037	49	31	bpm	bpm	NOUN
ecj-10037	49	32	)	)	PUNCT
ecj-10037	49	33	140	140	NUM
ecj-10037	49	34	88	88	NUM
ecj-10037	49	35	120	120	NUM
ecj-10037	49	36	95	95	NUM
ecj-10037	49	37	90	90	NUM
ecj-10037	49	38	85	85	NUM
ecj-10037	49	39	rr	rr	NOUN
ecj-10037	49	40	20	20	NUM
ecj-10037	49	41	16	16	NUM
ecj-10037	49	42	16	16	NUM
ecj-10037	49	43	bp	bp	PROPN
ecj-10037	49	44	(	(	PUNCT
ecj-10037	49	45	sys	sys	PROPN
ecj-10037	49	46	mmhg	mmhg	PROPN
ecj-10037	49	47	)	)	PUNCT
ecj-10037	49	48	158	158	NUM
ecj-10037	49	49	130	130	NUM
ecj-10037	49	50	133	133	NUM
ecj-10037	49	51	133	133	NUM
ecj-10037	49	52	122	122	NUM
ecj-10037	49	53	120	120	NUM
ecj-10037	49	54	130	130	NUM
ecj-10037	49	55	bp	bp	PROPN
ecj-10037	49	56	(	(	PUNCT
ecj-10037	49	57	dia	dia	PROPN
ecj-10037	49	58	mmhg	mmhg	PROPN
ecj-10037	49	59	)	)	PUNCT
ecj-10037	49	60	116	116	NUM
ecj-10037	49	61	60	60	NUM
ecj-10037	49	62	72	72	NUM
ecj-10037	49	63	72	72	NUM
ecj-10037	49	64	82	82	NUM
ecj-10037	49	65	70	70	NUM
ecj-10037	49	66	79	79	NUM
ecj-10037	49	67	bt	bt	NOUN
ecj-10037	49	68	(	(	PUNCT
ecj-10037	49	69	c	c	NOUN
ecj-10037	49	70	°	°	PRON
ecj-10037	49	71	)	)	PUNCT
ecj-10037	49	72	36	36	NUM
ecj-10037	49	73	36	36	NUM
ecj-10037	49	74	36.9	36.9	NUM
ecj-10037	49	75	36	36	NUM
ecj-10037	49	76	36	36	NUM
ecj-10037	49	77	36.7	36.7	NUM
ecj-10037	49	78	pain	pain	NOUN
ecj-10037	49	79	(	(	PUNCT
ecj-10037	49	80	vas	vas	X
ecj-10037	49	81	)	)	PUNCT
ecj-10037	49	82	1	1	NUM
ecj-10037	49	83	0	0	NUM
ecj-10037	49	84	gcs	gcs	PROPN
ecj-10037	49	85	15	15	NUM
ecj-10037	49	86	15	15	NUM
ecj-10037	49	87	15	15	NUM
ecj-10037	49	88	15	15	NUM
ecj-10037	49	89	15	15	NUM
ecj-10037	49	90	spo2	spo2	PROPN
ecj-10037	49	91	(	(	PUNCT
ecj-10037	49	92	%	%	INTJ
ecj-10037	49	93	aa	aa	INTJ
ecj-10037	49	94	)	)	PUNCT
ecj-10037	49	95	97	97	NUM
ecj-10037	49	96	97	97	NUM
ecj-10037	49	97	99	99	NUM
ecj-10037	49	98	98	98	NUM
ecj-10037	49	99	98	98	NUM
ecj-10037	49	100	96	96	NUM
ecj-10037	49	101	semi	semi	ADJ
ecj-10037	49	102	-	-	ADJ
ecj-10037	49	103	quantitative	quantitative	ADJ
ecj-10037	49	104	day	day	NOUN
ecj-10037	49	105	2	2	NUM
ecj-10037	49	106	09:54	09:54	NUM
ecj-10037	49	107	am	be	AUX
ecj-10037	49	108	amphetamine	amphetamine	PROPN
ecj-10037	49	109	benzodiazepines+	benzodiazepines+	ADP
ecj-10037	49	110	cannabinoids	cannabinoid	NOUN
ecj-10037	49	111	cocaine	cocaine	NOUN
ecj-10037	49	112	methadone	methadone	NOUN
ecj-10037	49	113	opioids	opioid	NOUN
ecj-10037	49	114	screening	screen	VERB
ecj-10037	49	115	(	(	PUNCT
ecj-10037	49	116	urine	urine	NOUN
ecj-10037	49	117	)	)	PUNCT
ecj-10037	50	1	[	[	X
ecj-10037	50	2	page	page	NOUN
ecj-10037	50	3	46	46	NUM
ecj-10037	50	4	]	]	PUNCT
ecj-10037	51	1	[	[	X
ecj-10037	51	2	emergency	emergency	NOUN
ecj-10037	51	3	care	care	NOUN
ecj-10037	51	4	journal	journal	PROPN
ecj-10037	51	5	2021	2021	NUM
ecj-10037	51	6	;	;	PUNCT
ecj-10037	51	7	17:10037	17:10037	NUM
ecj-10037	51	8	]	]	X
ecj-10037	51	9	non	non	ADJ
ecj-10037	51	10	-co	-co	PROPN
ecj-10037	51	11	mmerc	mmerc	PROPN
ecj-10037	51	12	ial	ial	PROPN
ecj-10037	51	13	us	us	PROPN
ecj-10037	51	14	e	e	NOUN
ecj-10037	51	15	o	o	NOUN
ecj-10037	51	16	nly	nly	ADV
ecj-10037	51	17	italian	italian	ADJ
ecj-10037	51	18	market	market	NOUN
ecj-10037	51	19	,	,	PUNCT
ecj-10037	51	20	making	make	VERB
ecj-10037	51	21	the	the	DET
ecj-10037	51	22	possible	possible	ADJ
ecj-10037	51	23	total	total	ADJ
ecj-10037	51	24	intranasal	intranasal	NOUN
ecj-10037	51	25	intake	intake	NOUN
ecj-10037	51	26	ranging	range	VERB
ecj-10037	51	27	from	from	ADP
ecj-10037	51	28	4,5	4,5	NUM
ecj-10037	51	29	g	g	NOUN
ecj-10037	51	30	to	to	ADP
ecj-10037	51	31	9	9	NUM
ecj-10037	51	32	g.	g.	NOUN
ecj-10037	51	33	second	second	ADJ
ecj-10037	51	34	-	-	PUNCT
ecj-10037	51	35	level	level	NOUN
ecj-10037	51	36	forensic	forensic	ADJ
ecj-10037	51	37	investigation	investigation	NOUN
ecj-10037	51	38	assessed	assess	VERB
ecj-10037	51	39	an	an	DET
ecj-10037	51	40	18	18	NUM
ecj-10037	51	41	-	-	PUNCT
ecj-10037	51	42	hour	hour	NOUN
ecj-10037	51	43	blood	blood	NOUN
ecj-10037	51	44	bupropion	bupropion	NOUN
ecj-10037	51	45	level	level	NOUN
ecj-10037	51	46	of	of	ADP
ecj-10037	51	47	1905,26	1905,26	PROPN
ecj-10037	51	48	ng	ng	PROPN
ecj-10037	51	49	/	/	SYM
ecj-10037	51	50	ml	ml	PROPN
ecj-10037	51	51	,	,	PUNCT
ecj-10037	51	52	estimating	estimate	VERB
ecj-10037	51	53	this	this	DET
ecj-10037	51	54	way	way	NOUN
ecj-10037	51	55	an	an	DET
ecj-10037	51	56	approximate	approximate	ADJ
ecj-10037	51	57	6	6	NUM
ecj-10037	51	58	g	g	NOUN
ecj-10037	51	59	intake	intake	NOUN
ecj-10037	51	60	consistent	consistent	ADJ
ecj-10037	51	61	with	with	ADP
ecj-10037	51	62	the	the	DET
ecj-10037	51	63	number	number	NOUN
ecj-10037	51	64	of	of	ADP
ecj-10037	51	65	tablets	tablet	NOUN
ecj-10037	51	66	stated	state	VERB
ecj-10037	51	67	by	by	ADP
ecj-10037	51	68	our	our	PRON
ecj-10037	51	69	patient	patient	NOUN
ecj-10037	51	70	(	(	PUNCT
ecj-10037	51	71	anecdotal	anecdotal	ADJ
ecj-10037	51	72	computation	computation	NOUN
ecj-10037	51	73	given	give	VERB
ecj-10037	51	74	the	the	DET
ecj-10037	51	75	different	different	ADJ
ecj-10037	51	76	oral	oral	NOUN
ecj-10037	51	77	versus	versus	ADP
ecj-10037	51	78	nasal	nasal	PROPN
ecj-10037	51	79	route	route	PROPN
ecj-10037	51	80	of	of	ADP
ecj-10037	51	81	administration	administration	NOUN
ecj-10037	51	82	)	)	PUNCT
ecj-10037	51	83	.	.	PUNCT
ecj-10037	52	1	considering	consider	VERB
ecj-10037	52	2	that	that	DET
ecj-10037	52	3	decontamination	decontamination	NOUN
ecj-10037	52	4	would	would	AUX
ecj-10037	52	5	not	not	PART
ecj-10037	52	6	be	be	AUX
ecj-10037	52	7	effective	effective	ADJ
ecj-10037	52	8	after	after	ADP
ecj-10037	52	9	intranasal	intranasal	ADJ
ecj-10037	52	10	misuse	misuse	NOUN
ecj-10037	52	11	,	,	PUNCT
ecj-10037	52	12	this	this	DET
ecj-10037	52	13	case	case	NOUN
ecj-10037	52	14	suggests	suggest	VERB
ecj-10037	52	15	that	that	SCONJ
ecj-10037	52	16	this	this	DET
ecj-10037	52	17	administration	administration	NOUN
ecj-10037	52	18	route	route	NOUN
ecj-10037	52	19	might	might	AUX
ecj-10037	52	20	have	have	VERB
ecj-10037	52	21	less	less	ADJ
ecj-10037	52	22	or	or	CCONJ
ecj-10037	52	23	slower	slow	ADJ
ecj-10037	52	24	absorption	absorption	NOUN
ecj-10037	52	25	compared	compare	VERB
ecj-10037	52	26	to	to	ADP
ecj-10037	52	27	an	an	DET
ecj-10037	52	28	almost	almost	ADV
ecj-10037	52	29	100	100	NUM
ecj-10037	52	30	%	%	NOUN
ecj-10037	52	31	absorption	absorption	NOUN
ecj-10037	52	32	by	by	ADP
ecj-10037	52	33	enteral	enteral	ADJ
ecj-10037	52	34	route4	route4	PROPN
ecj-10037	52	35	,	,	PUNCT
ecj-10037	52	36	differently	differently	ADV
ecj-10037	52	37	from	from	ADP
ecj-10037	52	38	what	what	PRON
ecj-10037	52	39	happens	happen	VERB
ecj-10037	52	40	with	with	ADP
ecj-10037	52	41	other	other	ADJ
ecj-10037	52	42	typical	typical	ADJ
ecj-10037	52	43	snorted	snorted	ADJ
ecj-10037	52	44	stimulants	stimulant	NOUN
ecj-10037	52	45	(	(	PUNCT
ecj-10037	52	46	e.g.	e.g.	ADV
ecj-10037	52	47	cocaine	cocaine	NOUN
ecj-10037	52	48	)	)	PUNCT
ecj-10037	52	49	that	that	PRON
ecj-10037	52	50	have	have	VERB
ecj-10037	52	51	faster	fast	ADJ
ecj-10037	52	52	intranasal	intranasal	ADJ
ecj-10037	52	53	intoxication	intoxication	NOUN
ecj-10037	52	54	in	in	ADP
ecj-10037	52	55	contrast	contrast	NOUN
ecj-10037	52	56	to	to	ADP
ecj-10037	52	57	its	its	PRON
ecj-10037	52	58	ingestion.18	ingestion.18	PROPN
ecj-10037	52	59	furthermore	furthermore	ADV
ecj-10037	52	60	,	,	PUNCT
ecj-10037	52	61	neurologic	neurologic	ADJ
ecj-10037	52	62	complications	complication	NOUN
ecj-10037	52	63	are	be	AUX
ecj-10037	52	64	usually	usually	ADV
ecj-10037	52	65	more	more	ADV
ecj-10037	52	66	likely	likely	ADJ
ecj-10037	52	67	above	above	ADP
ecj-10037	52	68	450	450	NUM
ecj-10037	52	69	mg	mg	NOUN
ecj-10037	52	70	dosing.6	dosing.6	NOUN
ecj-10037	52	71	this	this	DET
ecj-10037	52	72	case	case	NOUN
ecj-10037	52	73	may	may	AUX
ecj-10037	52	74	imply	imply	VERB
ecj-10037	52	75	that	that	SCONJ
ecj-10037	52	76	chronic	chronic	ADJ
ecj-10037	52	77	abusers	abuser	NOUN
ecj-10037	52	78	may	may	AUX
ecj-10037	52	79	not	not	PART
ecj-10037	52	80	be	be	AUX
ecj-10037	52	81	as	as	ADV
ecj-10037	52	82	sensitive	sensitive	ADJ
ecj-10037	52	83	to	to	ADP
ecj-10037	52	84	average	average	ADJ
ecj-10037	52	85	toxic	toxic	ADJ
ecj-10037	52	86	levels	level	NOUN
ecj-10037	52	87	as	as	ADP
ecj-10037	52	88	naïve	naïve	ADJ
ecj-10037	52	89	or	or	CCONJ
ecj-10037	52	90	therapeutic	therapeutic	ADJ
ecj-10037	52	91	use	use	NOUN
ecj-10037	52	92	patients	patient	NOUN
ecj-10037	52	93	,	,	PUNCT
ecj-10037	52	94	as	as	SCONJ
ecj-10037	52	95	was	be	AUX
ecj-10037	52	96	also	also	ADV
ecj-10037	52	97	reported	report	VERB
ecj-10037	52	98	on	on	ADP
ecj-10037	52	99	a	a	DET
ecj-10037	52	100	case	case	NOUN
ecj-10037	52	101	of	of	ADP
ecj-10037	52	102	2.1	2.1	NUM
ecj-10037	52	103	g	g	NOUN
ecj-10037	52	104	snorting	snort	VERB
ecj-10037	52	105	without	without	ADP
ecj-10037	52	106	seizures	seizure	NOUN
ecj-10037	52	107	occurrence.19	occurrence.19	NOUN
ecj-10037	52	108	another	another	DET
ecj-10037	52	109	interesting	interesting	ADJ
ecj-10037	52	110	aspect	aspect	NOUN
ecj-10037	52	111	that	that	PRON
ecj-10037	52	112	could	could	AUX
ecj-10037	52	113	be	be	AUX
ecj-10037	52	114	considered	consider	VERB
ecj-10037	52	115	is	be	AUX
ecj-10037	52	116	the	the	DET
ecj-10037	52	117	different	different	ADJ
ecj-10037	52	118	amount	amount	NOUN
ecj-10037	52	119	of	of	ADP
ecj-10037	52	120	active	active	ADJ
ecj-10037	52	121	metabolites	metabolite	NOUN
ecj-10037	52	122	after	after	ADP
ecj-10037	52	123	nasal	nasal	PROPN
ecj-10037	52	124	overdose	overdose	PROPN
ecj-10037	52	125	compared	compare	VERB
ecj-10037	52	126	to	to	ADP
ecj-10037	52	127	ingestion	ingestion	NOUN
ecj-10037	52	128	,	,	PUNCT
ecj-10037	52	129	due	due	ADP
ecj-10037	52	130	to	to	ADP
ecj-10037	52	131	lesser	less	ADJ
ecj-10037	52	132	intestinal	intestinal	ADJ
ecj-10037	52	133	/	/	SYM
ecj-10037	52	134	hepatic	hepatic	NOUN
ecj-10037	52	135	metabolism.20	metabolism.20	NOUN
ecj-10037	52	136	this	this	PRON
ecj-10037	52	137	could	could	AUX
ecj-10037	52	138	possibly	possibly	ADV
ecj-10037	52	139	explain	explain	VERB
ecj-10037	52	140	a	a	DET
ecj-10037	52	141	milder	mild	ADJ
ecj-10037	52	142	clinical	clinical	ADJ
ecj-10037	52	143	presentation	presentation	NOUN
ecj-10037	52	144	despite	despite	SCONJ
ecj-10037	52	145	high	high	ADJ
ecj-10037	52	146	dosages	dosage	NOUN
ecj-10037	52	147	.	.	PUNCT
ecj-10037	53	1	in	in	ADP
ecj-10037	53	2	spite	spite	NOUN
ecj-10037	53	3	of	of	ADP
ecj-10037	53	4	the	the	DET
ecj-10037	53	5	known	know	VERB
ecj-10037	53	6	bupropion	bupropion	NOUN
ecj-10037	53	7	cross	cross	NOUN
ecj-10037	53	8	reactivity	reactivity	NOUN
ecj-10037	53	9	for	for	ADP
ecj-10037	53	10	amphetamines,21	amphetamines,21	NOUN
ecj-10037	53	11	only	only	ADV
ecj-10037	53	12	iatrogenic	iatrogenic	ADJ
ecj-10037	53	13	bzd	bzd	NOUN
ecj-10037	53	14	were	be	AUX
ecj-10037	53	15	found	find	VERB
ecj-10037	53	16	in	in	ADP
ecj-10037	53	17	the	the	DET
ecj-10037	53	18	patient	patient	NOUN
ecj-10037	53	19	’s	’s	PART
ecj-10037	53	20	initial	initial	ADJ
ecj-10037	53	21	urine	urine	NOUN
ecj-10037	53	22	screening	screening	NOUN
ecj-10037	53	23	,	,	PUNCT
ecj-10037	53	24	requiring	require	VERB
ecj-10037	53	25	further	further	ADJ
ecj-10037	53	26	investigations	investigation	NOUN
ecj-10037	53	27	as	as	SCONJ
ecj-10037	53	28	to	to	PART
ecj-10037	53	29	confirm	confirm	VERB
ecj-10037	53	30	the	the	DET
ecj-10037	53	31	reported	reported	ADJ
ecj-10037	53	32	source	source	NOUN
ecj-10037	53	33	of	of	ADP
ecj-10037	53	34	intoxication	intoxication	NOUN
ecj-10037	53	35	.	.	PUNCT
ecj-10037	54	1	high	high	ADJ
ecj-10037	54	2	levels	level	NOUN
ecj-10037	54	3	of	of	ADP
ecj-10037	54	4	the	the	DET
ecj-10037	54	5	original	original	ADJ
ecj-10037	54	6	compound	compound	NOUN
ecj-10037	54	7	were	be	AUX
ecj-10037	54	8	indeed	indeed	ADV
ecj-10037	54	9	assessed	assess	VERB
ecj-10037	54	10	even	even	ADV
ecj-10037	54	11	after	after	ADP
ecj-10037	54	12	18	18	NUM
ecj-10037	54	13	hours	hour	NOUN
ecj-10037	54	14	from	from	ADP
ecj-10037	54	15	misuse	misuse	NOUN
ecj-10037	54	16	.	.	PUNCT
ecj-10037	55	1	this	this	PRON
ecj-10037	55	2	stresses	stress	VERB
ecj-10037	55	3	the	the	DET
ecj-10037	55	4	idea	idea	NOUN
ecj-10037	55	5	that	that	SCONJ
ecj-10037	55	6	expectancy	expectancy	NOUN
ecj-10037	55	7	for	for	ADP
ecj-10037	55	8	urinary	urinary	ADJ
ecj-10037	55	9	cross	cross	NOUN
ecj-10037	55	10	reactivity	reactivity	NOUN
ecj-10037	55	11	at	at	ADP
ecj-10037	55	12	standard	standard	ADJ
ecj-10037	55	13	screenings	screening	NOUN
ecj-10037	55	14	can	can	AUX
ecj-10037	55	15	underestimate	underestimate	VERB
ecj-10037	55	16	the	the	DET
ecj-10037	55	17	real	real	ADJ
ecj-10037	55	18	incidence	incidence	NOUN
ecj-10037	55	19	of	of	ADP
ecj-10037	55	20	bupropion	bupropion	NOUN
ecj-10037	55	21	abusers	abuser	NOUN
ecj-10037	55	22	and	and	CCONJ
ecj-10037	55	23	it	it	PRON
ecj-10037	55	24	should	should	AUX
ecj-10037	55	25	be	be	AUX
ecj-10037	55	26	taken	take	VERB
ecj-10037	55	27	with	with	ADP
ecj-10037	55	28	a	a	DET
ecj-10037	55	29	grain	grain	NOUN
ecj-10037	55	30	of	of	ADP
ecj-10037	55	31	salt	salt	NOUN
ecj-10037	55	32	.	.	PUNCT
ecj-10037	56	1	as	as	SCONJ
ecj-10037	56	2	previously	previously	ADV
ecj-10037	56	3	reported	report	VERB
ecj-10037	56	4	by	by	ADP
ecj-10037	56	5	other	other	ADJ
ecj-10037	56	6	authors,22	authors,22	NOUN
ecj-10037	56	7	leukocytosis	leukocytosis	NOUN
ecj-10037	56	8	can	can	AUX
ecj-10037	56	9	be	be	AUX
ecj-10037	56	10	found	find	VERB
ecj-10037	56	11	in	in	ADP
ecj-10037	56	12	case	case	NOUN
ecj-10037	56	13	of	of	ADP
ecj-10037	56	14	oral	oral	ADJ
ecj-10037	56	15	bupropion	bupropion	NOUN
ecj-10037	56	16	overdose	overdose	NOUN
ecj-10037	56	17	.	.	PUNCT
ecj-10037	57	1	our	our	PRON
ecj-10037	57	2	case	case	NOUN
ecj-10037	57	3	,	,	PUNCT
ecj-10037	57	4	despite	despite	SCONJ
ecj-10037	57	5	the	the	DET
ecj-10037	57	6	different	different	ADJ
ecj-10037	57	7	route	route	NOUN
ecj-10037	57	8	of	of	ADP
ecj-10037	57	9	exposition	exposition	NOUN
ecj-10037	57	10	,	,	PUNCT
ecj-10037	57	11	was	be	AUX
ecj-10037	57	12	consistent	consistent	ADJ
ecj-10037	57	13	with	with	ADP
ecj-10037	57	14	this	this	DET
ecj-10037	57	15	aspect	aspect	NOUN
ecj-10037	57	16	.	.	PUNCT
ecj-10037	58	1	eventually	eventually	ADV
ecj-10037	58	2	,	,	PUNCT
ecj-10037	58	3	in	in	ADP
ecj-10037	58	4	this	this	DET
ecj-10037	58	5	case	case	NOUN
ecj-10037	58	6	report	report	NOUN
ecj-10037	58	7	we	we	PRON
ecj-10037	58	8	would	would	AUX
ecj-10037	58	9	like	like	VERB
ecj-10037	58	10	to	to	PART
ecj-10037	58	11	underline	underline	VERB
ecj-10037	58	12	the	the	DET
ecj-10037	58	13	chance	chance	NOUN
ecj-10037	58	14	that	that	SCONJ
ecj-10037	58	15	bupropion	bupropion	PROPN
ecj-10037	58	16	nasal	nasal	PROPN
ecj-10037	58	17	exposure	exposure	PROPN
ecj-10037	58	18	toxicokinetic	toxicokinetic	PROPN
ecj-10037	58	19	may	may	AUX
ecj-10037	58	20	differ	differ	VERB
ecj-10037	58	21	from	from	ADP
ecj-10037	58	22	classical	classical	ADJ
ecj-10037	58	23	enteral	enteral	ADJ
ecj-10037	58	24	intoxication	intoxication	NOUN
ecj-10037	58	25	.	.	PUNCT
ecj-10037	59	1	still	still	ADV
ecj-10037	59	2	,	,	PUNCT
ecj-10037	59	3	symptomatic	symptomatic	ADJ
ecj-10037	59	4	treatment	treatment	NOUN
ecj-10037	59	5	of	of	ADP
ecj-10037	59	6	mild	mild	ADJ
ecj-10037	59	7	presentations	presentation	NOUN
ecj-10037	59	8	with	with	ADP
ecj-10037	59	9	bzd	bzd	PROPN
ecj-10037	59	10	remains	remain	VERB
ecj-10037	59	11	the	the	DET
ecj-10037	59	12	gold	gold	ADJ
ecj-10037	59	13	standard	standard	NOUN
ecj-10037	59	14	for	for	ADP
ecj-10037	59	15	preventing	prevent	VERB
ecj-10037	59	16	complications	complication	NOUN
ecj-10037	59	17	such	such	ADJ
ecj-10037	59	18	as	as	ADP
ecj-10037	59	19	seizures	seizure	NOUN
ecj-10037	59	20	and	and	CCONJ
ecj-10037	59	21	life	life	NOUN
ecj-10037	59	22	-	-	PUNCT
ecj-10037	59	23	threatening	threaten	VERB
ecj-10037	59	24	arrhythmias	arrhythmia	NOUN
ecj-10037	59	25	.	.	PUNCT
ecj-10037	60	1	because	because	SCONJ
ecj-10037	60	2	of	of	ADP
ecj-10037	60	3	its	its	PRON
ecj-10037	60	4	“	"	PUNCT
ecj-10037	60	5	cathinone	cathinone	NOUN
ecj-10037	60	6	-	-	PUNCT
ecj-10037	60	7	like	like	ADJ
ecj-10037	60	8	”	"	PUNCT
ecj-10037	60	9	properties	property	NOUN
ecj-10037	60	10	,	,	PUNCT
ecj-10037	60	11	bupropion	bupropion	NOUN
ecj-10037	60	12	results	result	NOUN
ecj-10037	60	13	among	among	ADP
ecj-10037	60	14	the	the	DET
ecj-10037	60	15	most	most	ADV
ecj-10037	60	16	frequent	frequent	ADJ
ecj-10037	60	17	antidepressants	antidepressant	NOUN
ecj-10037	60	18	prone	prone	ADJ
ecj-10037	60	19	to	to	ADP
ecj-10037	60	20	pharming	pharme	VERB
ecj-10037	60	21	and	and	CCONJ
ecj-10037	60	22	this	this	DET
ecj-10037	60	23	highlights	highlight	NOUN
ecj-10037	60	24	the	the	DET
ecj-10037	60	25	need	need	NOUN
ecj-10037	60	26	for	for	ADP
ecj-10037	60	27	a	a	DET
ecj-10037	60	28	more	more	ADV
ecj-10037	60	29	vigilant	vigilant	ADJ
ecj-10037	60	30	monitoring	monitoring	NOUN
ecj-10037	60	31	by	by	ADP
ecj-10037	60	32	healthcare	healthcare	NOUN
ecj-10037	60	33	professionals	professional	NOUN
ecj-10037	60	34	both	both	CCONJ
ecj-10037	60	35	in	in	ADP
ecj-10037	60	36	prescribing	prescribing	NOUN
ecj-10037	60	37	and	and	CCONJ
ecj-10037	60	38	selling	sell	VERB
ecj-10037	60	39	medications	medication	NOUN
ecj-10037	60	40	,	,	PUNCT
ecj-10037	60	41	especially	especially	ADV
ecj-10037	60	42	as	as	ADV
ecj-10037	60	43	long	long	ADJ
ecj-10037	60	44	as	as	SCONJ
ecj-10037	60	45	specific	specific	ADJ
ecj-10037	60	46	categories	category	NOUN
ecj-10037	60	47	are	be	AUX
ecj-10037	60	48	involved	involve	VERB
ecj-10037	60	49	(	(	PUNCT
ecj-10037	60	50	e.g.	e.g.	ADV
ecj-10037	60	51	unfamiliar	unfamiliar	ADJ
ecj-10037	60	52	patients	patient	NOUN
ecj-10037	60	53	or	or	CCONJ
ecj-10037	60	54	past	past	ADP
ecj-10037	60	55	sud	sud	NOUN
ecj-10037	60	56	patients	patient	NOUN
ecj-10037	60	57	)	)	PUNCT
ecj-10037	60	58	and	and	CCONJ
ecj-10037	60	59	urine	urine	NOUN
ecj-10037	60	60	screenings	screening	NOUN
ecj-10037	60	61	may	may	AUX
ecj-10037	60	62	not	not	PART
ecj-10037	60	63	always	always	ADV
ecj-10037	60	64	detect	detect	VERB
ecj-10037	60	65	the	the	DET
ecj-10037	60	66	misused	misused	ADJ
ecj-10037	60	67	substance	substance	NOUN
ecj-10037	60	68	.	.	PUNCT
ecj-10037	61	1	prompt	prompt	ADJ
ecj-10037	61	2	pcc	pcc	PROPN
ecj-10037	61	3	consultation	consultation	NOUN
ecj-10037	61	4	enables	enable	VERB
ecj-10037	61	5	health	health	NOUN
ecj-10037	61	6	providers	provider	NOUN
ecj-10037	61	7	to	to	PART
ecj-10037	61	8	effectively	effectively	ADV
ecj-10037	61	9	manage	manage	VERB
ecj-10037	61	10	intoxications	intoxication	NOUN
ecj-10037	61	11	deriving	derive	VERB
ecj-10037	61	12	from	from	ADP
ecj-10037	61	13	unordinary	unordinary	ADJ
ecj-10037	61	14	administration	administration	NOUN
ecj-10037	61	15	routes	route	NOUN
ecj-10037	61	16	for	for	ADP
ecj-10037	61	17	medication	medication	NOUN
ecj-10037	61	18	misuse	misuse	NOUN
ecj-10037	61	19	.	.	PUNCT
ecj-10037	62	1	references	reference	NOUN
ecj-10037	62	2	1	1	NUM
ecj-10037	62	3	.	.	PUNCT
ecj-10037	62	4	chiappini	chiappini	PROPN
ecj-10037	62	5	s	s	PROPN
ecj-10037	62	6	,	,	PUNCT
ecj-10037	62	7	schifano	schifano	PROPN
ecj-10037	62	8	f.	f.	PROPN
ecj-10037	62	9	what	what	PRON
ecj-10037	62	10	about	about	ADP
ecj-10037	62	11	“	"	PUNCT
ecj-10037	62	12	pharming	pharme	VERB
ecj-10037	62	13	”	"	PUNCT
ecj-10037	62	14	?	?	PUNCT
ecj-10037	63	1	issues	issue	NOUN
ecj-10037	63	2	regarding	regard	VERB
ecj-10037	63	3	the	the	DET
ecj-10037	63	4	misuse	misuse	NOUN
ecj-10037	63	5	of	of	ADP
ecj-10037	63	6	prescription	prescription	NOUN
ecj-10037	63	7	and	and	CCONJ
ecj-10037	63	8	over	over	ADP
ecj-10037	63	9	-	-	PUNCT
ecj-10037	63	10	the	the	DET
ecj-10037	63	11	-	-	PUNCT
ecj-10037	63	12	counter	counter	NOUN
ecj-10037	63	13	drugs	drug	NOUN
ecj-10037	63	14	.	.	PUNCT
ecj-10037	64	1	brain	brain	NOUN
ecj-10037	64	2	sci	sci	PROPN
ecj-10037	64	3	2020;10:736	2020;10:736	PROPN
ecj-10037	64	4	.	.	PROPN
ecj-10037	65	1	2	2	NUM
ecj-10037	65	2	.	.	X
ecj-10037	65	3	huecker	huecker	PROPN
ecj-10037	65	4	mr	mr	PROPN
ecj-10037	65	5	,	,	PUNCT
ecj-10037	65	6	smiley	smiley	NOUN
ecj-10037	65	7	a	a	PRON
ecj-10037	65	8	,	,	PUNCT
ecj-10037	65	9	saadabadi	saadabadi	NOUN
ecj-10037	65	10	a.	a.	NOUN
ecj-10037	65	11	bupropion	bupropion	NOUN
ecj-10037	65	12	.	.	PUNCT
ecj-10037	66	1	statpearls	statpearl	NOUN
ecj-10037	66	2	2021	2021	NUM
ecj-10037	66	3	.	.	PUNCT
ecj-10037	67	1	available	available	ADJ
ecj-10037	67	2	from	from	ADP
ecj-10037	67	3	:	:	PUNCT
ecj-10037	67	4	https://www.ncbi.nlm	https://www.ncbi.nlm	X
ecj-10037	67	5	.	.	PUNCT
ecj-10037	68	1	nih.gov/books/nbk470212/	nih.gov/books/nbk470212/	X
ecj-10037	69	1	3	3	X
ecj-10037	69	2	.	.	X
ecj-10037	69	3	trivedi	trivedi	PROPN
ecj-10037	69	4	mh	mh	PROPN
ecj-10037	69	5	,	,	PUNCT
ecj-10037	69	6	walker	walker	PROPN
ecj-10037	69	7	r	r	PROPN
ecj-10037	69	8	,	,	PUNCT
ecj-10037	69	9	ling	ling	PROPN
ecj-10037	69	10	w	w	PROPN
ecj-10037	69	11	,	,	PUNCT
ecj-10037	69	12	et	et	PROPN
ecj-10037	69	13	al	al	PROPN
ecj-10037	69	14	.	.	PROPN
ecj-10037	69	15	bupropion	bupropion	PROPN
ecj-10037	69	16	and	and	CCONJ
ecj-10037	69	17	naltrexone	naltrexone	PROPN
ecj-10037	69	18	in	in	ADP
ecj-10037	69	19	methamphetamine	methamphetamine	NOUN
ecj-10037	69	20	use	use	NOUN
ecj-10037	69	21	disorder	disorder	NOUN
ecj-10037	69	22	.	.	PUNCT
ecj-10037	70	1	new	new	ADJ
ecj-10037	70	2	engl	engl	PROPN
ecj-10037	70	3	jmed	jme	VERB
ecj-10037	70	4	2021;384:140–53	2021;384:140–53	PROPN
ecj-10037	70	5	.	.	PUNCT
ecj-10037	71	1	4	4	NUM
ecj-10037	71	2	.	.	X
ecj-10037	71	3	costa	costa	PROPN
ecj-10037	71	4	r	r	PROPN
ecj-10037	71	5	,	,	PUNCT
ecj-10037	71	6	oliveira	oliveira	PROPN
ecj-10037	71	7	ng	ng	PROPN
ecj-10037	71	8	,	,	PUNCT
ecj-10037	71	9	dinis	dinis	PROPN
ecj-10037	71	10	-	-	PUNCT
ecj-10037	71	11	oliveira	oliveira	PROPN
ecj-10037	71	12	rj	rj	PROPN
ecj-10037	71	13	.	.	PUNCT
ecj-10037	71	14	pharmacokinetic	pharmacokinetic	PROPN
ecj-10037	71	15	and	and	CCONJ
ecj-10037	71	16	pharmacodynamic	pharmacodynamic	ADJ
ecj-10037	71	17	of	of	ADP
ecj-10037	71	18	bupropion	bupropion	NOUN
ecj-10037	71	19	:	:	PUNCT
ecj-10037	71	20	integrative	integrative	ADJ
ecj-10037	71	21	overview	overview	NOUN
ecj-10037	71	22	of	of	ADP
ecj-10037	71	23	relevant	relevant	ADJ
ecj-10037	71	24	clinical	clinical	ADJ
ecj-10037	71	25	and	and	CCONJ
ecj-10037	71	26	forensic	forensic	ADJ
ecj-10037	71	27	aspects	aspect	NOUN
ecj-10037	71	28	.	.	PUNCT
ecj-10037	72	1	drug	drug	NOUN
ecj-10037	72	2	metabolism	metabolism	NOUN
ecj-10037	72	3	rev	rev	PROPN
ecj-10037	72	4	2019;51:293–313	2019;51:293–313	PROPN
ecj-10037	72	5	.	.	PROPN
ecj-10037	72	6	5	5	NUM
ecj-10037	72	7	.	.	X
ecj-10037	72	8	naglich	naglich	PROPN
ecj-10037	72	9	ac	ac	PROPN
ecj-10037	72	10	,	,	PUNCT
ecj-10037	72	11	brown	brown	ADJ
ecj-10037	72	12	es	es	NOUN
ecj-10037	72	13	,	,	PUNCT
ecj-10037	72	14	adinoff	adinoff	PROPN
ecj-10037	72	15	b.	b.	PROPN
ecj-10037	72	16	systematic	systematic	PROPN
ecj-10037	72	17	review	review	NOUN
ecj-10037	72	18	of	of	ADP
ecj-10037	72	19	preclinical	preclinical	ADJ
ecj-10037	72	20	,	,	PUNCT
ecj-10037	72	21	clinical	clinical	ADJ
ecj-10037	72	22	,	,	PUNCT
ecj-10037	72	23	and	and	CCONJ
ecj-10037	72	24	post	post	ADJ
ecj-10037	72	25	-	-	ADJ
ecj-10037	72	26	marketing	marketing	ADJ
ecj-10037	72	27	evidence	evidence	NOUN
ecj-10037	72	28	of	of	ADP
ecj-10037	72	29	bupropion	bupropion	NOUN
ecj-10037	72	30	misuse	misuse	NOUN
ecj-10037	72	31	potential	potential	NOUN
ecj-10037	72	32	.	.	PUNCT
ecj-10037	73	1	am	be	AUX
ecj-10037	73	2	j	j	PROPN
ecj-10037	73	3	drug	drug	NOUN
ecj-10037	73	4	alcohol	alcohol	NOUN
ecj-10037	73	5	abuse	abuse	NOUN
ecj-10037	73	6	.	.	PUNCT
ecj-10037	74	1	2019;45:341–54	2019;45:341–54	X
ecj-10037	74	2	.	.	NOUN
ecj-10037	75	1	6	6	NUM
ecj-10037	75	2	.	.	X
ecj-10037	75	3	starr	starr	PROPN
ecj-10037	75	4	p	p	PROPN
ecj-10037	75	5	,	,	PUNCT
ecj-10037	75	6	klein	klein	PROPN
ecj-10037	75	7	-	-	PUNCT
ecj-10037	75	8	schwartz	schwartz	PROPN
ecj-10037	75	9	w	w	PROPN
ecj-10037	75	10	,	,	PUNCT
ecj-10037	75	11	spiller	spiller	NOUN
ecj-10037	75	12	h	h	NOUN
ecj-10037	75	13	,	,	PUNCT
ecj-10037	75	14	et	et	PROPN
ecj-10037	75	15	al	al	PROPN
ecj-10037	75	16	.	.	PROPN
ecj-10037	75	17	incidence	incidence	NOUN
ecj-10037	75	18	and	and	CCONJ
ecj-10037	75	19	onset	onset	NOUN
ecj-10037	75	20	of	of	ADP
ecj-10037	75	21	delayed	delay	VERB
ecj-10037	75	22	seizures	seizure	NOUN
ecj-10037	75	23	after	after	ADP
ecj-10037	75	24	overdoses	overdose	NOUN
ecj-10037	75	25	of	of	ADP
ecj-10037	75	26	extended	extend	VERB
ecj-10037	75	27	-	-	PUNCT
ecj-10037	75	28	release	release	NOUN
ecj-10037	75	29	bupropion	bupropion	NOUN
ecj-10037	75	30	.	.	PUNCT
ecj-10037	76	1	am	be	AUX
ecj-10037	76	2	jemerg	jemerg	PROPN
ecj-10037	76	3	med	med	PROPN
ecj-10037	76	4	2009;27:911–5	2009;27:911–5	PROPN
ecj-10037	76	5	.	.	PUNCT
ecj-10037	77	1	7	7	X
ecj-10037	77	2	.	.	X
ecj-10037	77	3	morazin	morazin	PROPN
ecj-10037	77	4	f	f	PROPN
ecj-10037	77	5	,	,	PUNCT
ecj-10037	77	6	lumbroso	lumbroso	PROPN
ecj-10037	77	7	a	a	X
ecj-10037	77	8	,	,	PUNCT
ecj-10037	77	9	harry	harry	PROPN
ecj-10037	77	10	p	p	X
ecj-10037	77	11	,	,	PUNCT
ecj-10037	77	12	et	et	PROPN
ecj-10037	77	13	al	al	PROPN
ecj-10037	77	14	.	.	PROPN
ecj-10037	77	15	cardiogenic	cardiogenic	ADJ
ecj-10037	77	16	shock	shock	NOUN
ecj-10037	77	17	and	and	CCONJ
ecj-10037	77	18	status	status	NOUN
ecj-10037	77	19	epilepticus	epilepticus	NOUN
ecj-10037	77	20	after	after	ADP
ecj-10037	77	21	massive	massive	ADJ
ecj-10037	77	22	bupropion	bupropion	NOUN
ecj-10037	77	23	overdose	overdose	NOUN
ecj-10037	77	24	.	.	PUNCT
ecj-10037	78	1	clinical	clinical	ADJ
ecj-10037	78	2	toxicol	toxicol	PROPN
ecj-10037	78	3	2007;45:794–7	2007;45:794–7	NUM
ecj-10037	78	4	.	.	PROPN
ecj-10037	79	1	8	8	NUM
ecj-10037	79	2	.	.	PUNCT
ecj-10037	79	3	stassinos	stassinos	PROPN
ecj-10037	79	4	gl	gl	PROPN
ecj-10037	79	5	,	,	PUNCT
ecj-10037	79	6	klein	klein	PROPN
ecj-10037	79	7	-	-	PUNCT
ecj-10037	79	8	schwartz	schwartz	PROPN
ecj-10037	79	9	w.	w.	PROPN
ecj-10037	79	10	bupropion	bupropion	PROPN
ecj-10037	79	11	“	"	PUNCT
ecj-10037	79	12	abuse	abuse	NOUN
ecj-10037	79	13	”	"	PUNCT
ecj-10037	79	14	reported	report	VERB
ecj-10037	79	15	to	to	ADP
ecj-10037	79	16	us	we	PRON
ecj-10037	79	17	poison	poison	NOUN
ecj-10037	79	18	centers	center	NOUN
ecj-10037	79	19	.	.	PUNCT
ecj-10037	80	1	jaddict	jaddict	PROPN
ecj-10037	80	2	med	med	PROPN
ecj-10037	80	3	2016;10:357–62	2016;10:357–62	NUM
ecj-10037	80	4	.	.	PROPN
ecj-10037	80	5	9	9	NUM
ecj-10037	80	6	.	.	X
ecj-10037	80	7	hilliard	hilliard	PROPN
ecj-10037	80	8	wt	wt	PROPN
ecj-10037	80	9	,	,	PUNCT
ecj-10037	80	10	barloon	barloon	NOUN
ecj-10037	80	11	l	l	NOUN
ecj-10037	80	12	,	,	PUNCT
ecj-10037	80	13	farley	farley	PROPN
ecj-10037	80	14	p	p	PROPN
ecj-10037	80	15	,	,	PUNCT
ecj-10037	80	16	et	et	PROPN
ecj-10037	80	17	al	al	PROPN
ecj-10037	80	18	.	.	PROPN
ecj-10037	80	19	bupropion	bupropion	PROPN
ecj-10037	80	20	diversion	diversion	NOUN
ecj-10037	80	21	and	and	CCONJ
ecj-10037	80	22	misuse	misuse	NOUN
ecj-10037	80	23	in	in	ADP
ecj-10037	80	24	the	the	DET
ecj-10037	80	25	correctional	correctional	ADJ
ecj-10037	80	26	facility	facility	NOUN
ecj-10037	80	27	.	.	PUNCT
ecj-10037	81	1	jcorrect	jcorrect	PROPN
ecj-10037	81	2	health	health	PROPN
ecj-10037	81	3	care	care	PROPN
ecj-10037	81	4	2013;19:211–7	2013;19:211–7	NUM
ecj-10037	81	5	.	.	PUNCT
ecj-10037	81	6	10	10	NUM
ecj-10037	81	7	.	.	PUNCT
ecj-10037	82	1	welsh	welsh	PROPN
ecj-10037	82	2	cj	cj	PROPN
ecj-10037	82	3	,	,	PUNCT
ecj-10037	82	4	doyon	doyon	PROPN
ecj-10037	82	5	s.	s.	PROPN
ecj-10037	82	6	seizure	seizure	AUX
ecj-10037	82	7	induced	induce	VERB
ecj-10037	82	8	by	by	ADP
ecj-10037	82	9	insufflation	insufflation	NOUN
ecj-10037	82	10	of	of	ADP
ecj-10037	82	11	bupropion	bupropion	NOUN
ecj-10037	82	12	.	.	PUNCT
ecj-10037	83	1	new	new	ADJ
ecj-10037	83	2	engl	engl	PROPN
ecj-10037	83	3	jmed	jme	VERB
ecj-10037	83	4	2002:347:951	2002:347:951	NUM
ecj-10037	83	5	.	.	PUNCT
ecj-10037	84	1	11	11	NUM
ecj-10037	84	2	.	.	PUNCT
ecj-10037	85	1	sheridan	sheridan	PROPN
ecj-10037	85	2	dc	dc	PROPN
ecj-10037	85	3	,	,	PUNCT
ecj-10037	85	4	lin	lin	PROPN
ecj-10037	85	5	a	a	PRON
ecj-10037	85	6	,	,	PUNCT
ecj-10037	85	7	zane	zane	PROPN
ecj-10037	85	8	horowitz	horowitz	PROPN
ecj-10037	85	9	b.	b.	PROPN
ecj-10037	85	10	suicidal	suicidal	PROPN
ecj-10037	85	11	bupropion	bupropion	PROPN
ecj-10037	85	12	ingestions	ingestion	NOUN
ecj-10037	85	13	in	in	ADP
ecj-10037	85	14	adolescents	adolescent	NOUN
ecj-10037	85	15	:	:	PUNCT
ecj-10037	85	16	increased	increase	VERB
ecj-10037	85	17	morbidity	morbidity	NOUN
ecj-10037	85	18	compared	compare	VERB
ecj-10037	85	19	with	with	ADP
ecj-10037	85	20	other	other	ADJ
ecj-10037	85	21	antidepressants	antidepressant	NOUN
ecj-10037	85	22	.	.	PUNCT
ecj-10037	86	1	clinical	clinical	ADJ
ecj-10037	86	2	toxicol	toxicol	PROPN
ecj-10037	86	3	2018;56:360–4	2018;56:360–4	NUM
ecj-10037	86	4	.	.	PUNCT
ecj-10037	87	1	12	12	NUM
ecj-10037	87	2	.	.	PUNCT
ecj-10037	88	1	baribeau	baribeau	PROPN
ecj-10037	88	2	d	d	PROPN
ecj-10037	88	3	,	,	PUNCT
ecj-10037	88	4	araki	araki	PROPN
ecj-10037	88	5	kf	kf	PROPN
ecj-10037	88	6	.	.	PROPN
ecj-10037	88	7	intravenous	intravenous	ADJ
ecj-10037	88	8	bupropion	bupropion	NOUN
ecj-10037	88	9	.	.	PUNCT
ecj-10037	89	1	jaddict	jaddict	PROPN
ecj-10037	89	2	med	med	ADJ
ecj-10037	89	3	2013;7:216–7	2013;7:216–7	NOUN
ecj-10037	89	4	.	.	PUNCT
ecj-10037	90	1	13	13	NUM
ecj-10037	90	2	.	.	X
ecj-10037	90	3	strike	strike	PROPN
ecj-10037	90	4	m	m	PROPN
ecj-10037	90	5	,	,	PUNCT
ecj-10037	90	6	hatcher	hatcher	PROPN
ecj-10037	90	7	s.	s.	PROPN
ecj-10037	90	8	bupropion	bupropion	PROPN
ecj-10037	90	9	injection	injection	NOUN
ecj-10037	90	10	resulting	result	VERB
ecj-10037	90	11	in	in	ADP
ecj-10037	90	12	tissue	tissue	NOUN
ecj-10037	90	13	necrosis	necrosis	NOUN
ecj-10037	90	14	and	and	CCONJ
ecj-10037	90	15	psychosis	psychosis	NOUN
ecj-10037	90	16	.	.	PUNCT
ecj-10037	91	1	jaddict	jaddict	PROPN
ecj-10037	91	2	med	med	PROPN
ecj-10037	91	3	2015;9:246–50	2015;9:246–50	NUM
ecj-10037	91	4	.	.	PUNCT
ecj-10037	92	1	14	14	NUM
ecj-10037	92	2	.	.	PUNCT
ecj-10037	93	1	farkas	farkas	PROPN
ecj-10037	93	2	j.	j.	PROPN
ecj-10037	93	3	bupropion	bupropion	PROPN
ecj-10037	93	4	intoxication.internet	intoxication.internet	PROPN
ecj-10037	93	5	book	book	NOUN
ecj-10037	93	6	of	of	ADP
ecj-10037	93	7	critical	critical	ADJ
ecj-10037	93	8	care	care	NOUN
ecj-10037	93	9	.	.	PUNCT
ecj-10037	94	1	2019	2019	NUM
ecj-10037	94	2	.	.	PUNCT
ecj-10037	95	1	available	available	ADJ
ecj-10037	95	2	from	from	ADP
ecj-10037	95	3	:	:	PUNCT
ecj-10037	95	4	https://emcrit.org/ibcc/bupropion	https://emcrit.org/ibcc/bupropion	NOUN
ecj-10037	95	5	15	15	NUM
ecj-10037	95	6	.	.	PUNCT
ecj-10037	96	1	norwegian	norwegian	PROPN
ecj-10037	96	2	institute	institute	PROPN
ecj-10037	96	3	of	of	ADP
ecj-10037	96	4	public	public	ADJ
ecj-10037	96	5	health	health	PROPN
ecj-10037	96	6	.	.	PUNCT
ecj-10037	97	1	atc	atc	PROPN
ecj-10037	97	2	/	/	SYM
ecj-10037	97	3	ddd	ddd	PROPN
ecj-10037	97	4	index	index	NOUN
ecj-10037	97	5	.	.	PUNCT
ecj-10037	98	1	who	who	PRON
ecj-10037	98	2	collaborating	collaborate	VERB
ecj-10037	98	3	centre	centre	NOUN
ecj-10037	98	4	for	for	ADP
ecj-10037	98	5	drug	drug	NOUN
ecj-10037	98	6	statistics	statistic	NOUN
ecj-10037	98	7	methodology	methodology	NOUN
ecj-10037	98	8	.	.	PUNCT
ecj-10037	99	1	2020	2020	NUM
ecj-10037	99	2	.	.	PUNCT
ecj-10037	100	1	16	16	NUM
ecj-10037	100	2	.	.	PUNCT
ecj-10037	101	1	jefferson	jefferson	PROPN
ecj-10037	101	2	jw	jw	PROPN
ecj-10037	101	3	,	,	PUNCT
ecj-10037	101	4	pradko	pradko	PROPN
ecj-10037	101	5	jf	jf	PROPN
ecj-10037	101	6	,	,	PUNCT
ecj-10037	101	7	muir	muir	PROPN
ecj-10037	101	8	kt	kt	PROPN
ecj-10037	101	9	.	.	PROPN
ecj-10037	101	10	bupropion	bupropion	NOUN
ecj-10037	101	11	for	for	ADP
ecj-10037	101	12	major	major	ADJ
ecj-10037	101	13	depressive	depressive	ADJ
ecj-10037	101	14	disorder	disorder	NOUN
ecj-10037	101	15	:	:	PUNCT
ecj-10037	101	16	pharmacokinetic	pharmacokinetic	ADJ
ecj-10037	101	17	and	and	CCONJ
ecj-10037	101	18	formulation	formulation	NOUN
ecj-10037	101	19	considerations	consideration	NOUN
ecj-10037	101	20	.	.	PUNCT
ecj-10037	102	1	clinical	clinical	ADJ
ecj-10037	102	2	therapeutics	therapeutic	NOUN
ecj-10037	102	3	.	.	PUNCT
ecj-10037	103	1	2005;27:1685–95	2005;27:1685–95	NUM
ecj-10037	103	2	.	.	PUNCT
ecj-10037	104	1	17	17	NUM
ecj-10037	104	2	.	.	PUNCT
ecj-10037	105	1	preskorn	preskorn	ADJ
ecj-10037	105	2	sh	sh	PROPN
ecj-10037	105	3	.	.	PROPN
ecj-10037	105	4	antidepressant	antidepressant	ADJ
ecj-10037	105	5	response	response	NOUN
ecj-10037	105	6	and	and	CCONJ
ecj-10037	105	7	plasma	plasma	NOUN
ecj-10037	105	8	concentrations	concentration	NOUN
ecj-10037	105	9	of	of	ADP
ecj-10037	105	10	bupropion	bupropion	NOUN
ecj-10037	105	11	.	.	PUNCT
ecj-10037	106	1	jclinpsychiat	jclinpsychiat	PROPN
ecj-10037	106	2	1983;44:137–9	1983;44:137–9	NUM
ecj-10037	106	3	.	.	PUNCT
ecj-10037	107	1	18	18	NUM
ecj-10037	107	2	.	.	PUNCT
ecj-10037	108	1	nelson	nelson	PROPN
ecj-10037	108	2	ls	ls	PROPN
ecj-10037	108	3	,	,	PUNCT
ecj-10037	108	4	howland	howland	PROPN
ecj-10037	108	5	ma	ma	PROPN
ecj-10037	108	6	,	,	PUNCT
ecj-10037	108	7	lewin	lewin	PROPN
ecj-10037	108	8	na	na	PROPN
ecj-10037	108	9	,	,	PUNCT
ecj-10037	108	10	et	et	PROPN
ecj-10037	108	11	al	al	PROPN
ecj-10037	108	12	.	.	PROPN
ecj-10037	108	13	cocaine	cocaine	NOUN
ecj-10037	108	14	.	.	PUNCT
ecj-10037	109	1	nelson	nelson	PROPN
ecj-10037	109	2	l.s	l.s	PROPN
ecj-10037	109	3	.	.	PROPN
ecj-10037	109	4	,	,	PUNCT
ecj-10037	109	5	&	&	CCONJ
ecj-10037	109	6	howland	howland	PROPN
ecj-10037	109	7	m	m	PROPN
ecj-10037	109	8	,	,	PUNCT
ecj-10037	109	9	&	&	CCONJ
ecj-10037	109	10	lewin	lewin	PROPN
ecj-10037	109	11	n.a	n.a	PROPN
ecj-10037	109	12	.	.	PROPN
ecj-10037	109	13	,	,	PUNCT
ecj-10037	109	14	&	&	CCONJ
ecj-10037	109	15	smith	smith	PROPN
ecj-10037	109	16	s.w	s.w	PROPN
ecj-10037	109	17	.	.	PROPN
ecj-10037	109	18	,	,	PUNCT
ecj-10037	109	19	&	&	CCONJ
ecj-10037	109	20	goldfrank	goldfrank	PROPN
ecj-10037	109	21	l.r	l.r	PROPN
ecj-10037	109	22	.	.	PROPN
ecj-10037	109	23	,	,	PUNCT
ecj-10037	109	24	&	&	CCONJ
ecj-10037	109	25	hoffman	hoffman	PROPN
ecj-10037	109	26	r.s.(eds	r.s.(ed	NOUN
ecj-10037	109	27	.	.	PUNCT
ecj-10037	109	28	)	)	PUNCT
ecj-10037	110	1	,	,	PUNCT
ecj-10037	110	2	goldfrank	goldfrank	PROPN
ecj-10037	110	3	’s	’s	PART
ecj-10037	110	4	toxicologic	toxicologic	PROPN
ecj-10037	110	5	emergencies	emergency	NOUN
ecj-10037	110	6	,	,	PUNCT
ecj-10037	110	7	11e	11e	NUM
ecj-10037	110	8	.	.	PUNCT
ecj-10037	111	1	mcgraw	mcgraw	PROPN
ecj-10037	111	2	hill	hill	PROPN
ecj-10037	111	3	.	.	PUNCT
ecj-10037	112	1	available	available	ADJ
ecj-10037	112	2	from	from	ADP
ecj-10037	112	3	:	:	PUNCT
ecj-10037	112	4	https://accessemergencymedicine.mhmedical.com/content.asp	https://accessemergencymedicine.mhmedical.com/content.asp	NOUN
ecj-10037	112	5	x?bookid=2569&sectionid=210259752	x?bookid=2569&sectionid=210259752	ADP
ecj-10037	112	6	19	19	NUM
ecj-10037	112	7	.	.	PUNCT
ecj-10037	113	1	yoon	yoon	PROPN
ecj-10037	113	2	g	g	PROPN
ecj-10037	113	3	,	,	PUNCT
ecj-10037	113	4	westermeyer	westermeyer	PROPN
ecj-10037	113	5	j.	j.	PROPN
ecj-10037	113	6	intranasal	intranasal	PROPN
ecj-10037	113	7	bupropion	bupropion	PROPN
ecj-10037	113	8	abuse	abuse	NOUN
ecj-10037	113	9	.	.	PUNCT
ecj-10037	113	10	am	be	AUX
ecj-10037	113	11	jaddict	jaddict	PROPN
ecj-10037	113	12	2013;22:180	2013;22:180	NUM
ecj-10037	113	13	.	.	PUNCT
ecj-10037	114	1	20	20	NUM
ecj-10037	114	2	.	.	PUNCT
ecj-10037	115	1	costa	costa	PROPN
ecj-10037	115	2	r	r	PROPN
ecj-10037	115	3	,	,	PUNCT
ecj-10037	115	4	oliveira	oliveira	PROPN
ecj-10037	115	5	ng	ng	PROPN
ecj-10037	115	6	,	,	PUNCT
ecj-10037	115	7	dinis	dinis	PROPN
ecj-10037	115	8	-	-	PUNCT
ecj-10037	115	9	oliveira	oliveira	PROPN
ecj-10037	115	10	rj	rj	PROPN
ecj-10037	115	11	.	.	PUNCT
ecj-10037	115	12	pharmacokinetic	pharmacokinetic	PROPN
ecj-10037	115	13	and	and	CCONJ
ecj-10037	115	14	pharmacodynamic	pharmacodynamic	ADJ
ecj-10037	115	15	of	of	ADP
ecj-10037	115	16	bupropion	bupropion	NOUN
ecj-10037	115	17	:	:	PUNCT
ecj-10037	115	18	integrative	integrative	ADJ
ecj-10037	115	19	overview	overview	NOUN
ecj-10037	115	20	of	of	ADP
ecj-10037	115	21	relevant	relevant	ADJ
ecj-10037	115	22	clinical	clinical	ADJ
ecj-10037	115	23	and	and	CCONJ
ecj-10037	115	24	forensic	forensic	ADJ
ecj-10037	115	25	aspects	aspect	NOUN
ecj-10037	115	26	.	.	PUNCT
ecj-10037	116	1	drug	drug	NOUN
ecj-10037	116	2	metab	metab	PROPN
ecj-10037	116	3	rev	rev	VERB
ecj-10037	116	4	2019;51:293	2019;51:293	PROPN
ecj-10037	116	5	-	-	SYM
ecj-10037	116	6	313	313	NUM
ecj-10037	116	7	.	.	PUNCT
ecj-10037	117	1	21	21	NUM
ecj-10037	117	2	.	.	X
ecj-10037	118	1	casey	casey	PROPN
ecj-10037	118	2	er	er	INTJ
ecj-10037	118	3	,	,	PUNCT
ecj-10037	118	4	scott	scott	PROPN
ecj-10037	118	5	mg	mg	PROPN
ecj-10037	118	6	,	,	PUNCT
ecj-10037	118	7	tang	tang	PROPN
ecj-10037	118	8	s	s	PROPN
ecj-10037	118	9	,	,	PUNCT
ecj-10037	118	10	mullins	mullins	PROPN
ecj-10037	118	11	me	i	PRON
ecj-10037	118	12	.	.	PUNCT
ecj-10037	119	1	frequency	frequency	NOUN
ecj-10037	119	2	of	of	ADP
ecj-10037	119	3	false	false	ADJ
ecj-10037	119	4	positive	positive	ADJ
ecj-10037	119	5	amphetamine	amphetamine	NOUN
ecj-10037	119	6	screens	screen	NOUN
ecj-10037	119	7	due	due	ADP
ecj-10037	119	8	to	to	ADP
ecj-10037	119	9	bupropion	bupropion	NOUN
ecj-10037	119	10	using	use	VERB
ecj-10037	119	11	thesyva	thesyva	NOUN
ecj-10037	119	12	emit	emit	NOUN
ecj-10037	119	13	ii	ii	PROPN
ecj-10037	119	14	immunoassay	immunoassay	PROPN
ecj-10037	119	15	.	.	PUNCT
ecj-10037	120	1	jmed	jmed	PROPN
ecj-10037	120	2	toxicol	toxicol	PROPN
ecj-10037	120	3	2011;7:105–8	2011;7:105–8	NOUN
ecj-10037	120	4	.	.	PUNCT
ecj-10037	121	1	22	22	NUM
ecj-10037	121	2	.	.	PUNCT
ecj-10037	122	1	jolly	jolly	ADV
ecj-10037	122	2	ts	ts	ADP
ecj-10037	122	3	,	,	PUNCT
ecj-10037	122	4	singh	singh	PROPN
ecj-10037	122	5	j	j	PROPN
ecj-10037	122	6	,	,	PUNCT
ecj-10037	122	7	baweja	baweja	PROPN
ecj-10037	122	8	r.	r.	PROPN
ecj-10037	122	9	bupropion	bupropion	PROPN
ecj-10037	122	10	-	-	PUNCT
ecj-10037	122	11	induced	induce	VERB
ecj-10037	122	12	severe	severe	ADJ
ecj-10037	122	13	leukocytosis	leukocytosis	NOUN
ecj-10037	122	14	.	.	PUNCT
ecj-10037	123	1	cureus	cureus	PROPN
ecj-10037	123	2	2020;12	2020;12	NUM
ecj-10037	123	3	:	:	PUNCT
ecj-10037	123	4	e11083	e11083	NOUN
ecj-10037	123	5	.	.	PUNCT
ecj-10037	124	1	case	case	NOUN
ecj-10037	124	2	report	report	NOUN
ecj-10037	124	3	[	[	X
ecj-10037	124	4	emergency	emergency	NOUN
ecj-10037	124	5	care	care	NOUN
ecj-10037	124	6	journal	journal	PROPN
ecj-10037	124	7	2021	2021	NUM
ecj-10037	124	8	;	;	PUNCT
ecj-10037	124	9	17:10037	17:10037	NUM
ecj-10037	124	10	]	]	X
ecj-10037	125	1	[	[	X
ecj-10037	125	2	page	page	NOUN
ecj-10037	125	3	47	47	NUM
ecj-10037	125	4	]	]	PUNCT
ecj-10037	125	5	non	non	ADJ
ecj-10037	125	6	-co	-co	PROPN
ecj-10037	125	7	mmerc	mmerc	PROPN
ecj-10037	125	8	ial	ial	PROPN
ecj-10037	125	9	us	us	PROPN
ecj-10037	125	10	e	e	NOUN
ecj-10037	125	11	o	o	NOUN
ecj-10037	125	12	nly	nly	ADV